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The hypothalamus is a small, but anatomically and functionally complex, region of the 
brain.  Due in part to its anatomical complexity, its development is not well 
understood.  Here, we have explored its development by studying two different 
patterning mechanisms:  intrinsic factors, in the form of the transcription factor 
Foxd1, and extrinsic factors, via the canonical Wnt signaling pathway.  Foxd1 is 
expressed broadly throughout the hypothalamus and prethalamus early in 
development, but its function was unknown.  We generated Foxd1-/- mice and used a 
panel of in situ hybridization markers to study their development.  These mice have a 
very selective defect in the anterior hypothalamus, specifically the suprachiasmatic 
iii 
 
nucleus, periventricular nucleus and paraventricular nucleus. RNA-Seq analysis 
suggests that Foxd1 may be controlling anterior hypothalamic development through 
regulation of the transcription factors Six3 and Vax1.  We also studied the role of 
canonical Wnt signaling in the patterning of the hypothalamus and prethalamus by 
manipulating its effector protein, β-catenin by using Foxd1-Cre, which is expressed in 
both the hypothalamus and prethalamus.  Loss of β-catenin resulted in an 
anteriorization of the hypothalamus.  Posterior structures were lost or reduced, and 
anterior structures were expanded.  We also generated a mouse with constitutively 
active β-catenin through excision of its autoinhibitory domain.  In situ hybridization 
analysis of these mice revealed a complex phenotype where there was a general loss of 
most, but not all, markers of regional and nuclear identity.  However, the posterior 
hypothalamus was not only preserved, but potentially expanded.  In neither the loss- 
or gain-of-function mice was the patterning of the prethalamus affected.  However, in 
the gain-of-function mice, the prethalamus was only partially differentiated.  We next 
manipulated the Shh signaling pathway by generating a constitutively active form of 
its effector protein, Smo, which had no effect on patterning in the hypothalamus or 
prethalamus.  However, by crossing the constitutively active Smo mice to our 
constitutively active β-catenin mice, we were able to rescue the defects observed in the 
constitutively active β-catenin single mutant mice.  Thus, we have revealed an 
important interaction between two major signaling pathways in the development of 
the hypothalamus.  We have identified multiple novel mechanisms controlling 
iv 
 
development of the hypothalamus, although further research will need to be done to 
determine the exact methods by which they are directing patterning and 
differentiation.   
 
Readers: Seth Blackshaw and Jeremy Nathans 
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AH: anterior hypothalamus 
AP: anterior-posterior 
ArcN: arcuate nucleus 
BP: basal plate 
dlAH: dorsolateral anterior hypothalamus 
DMH: dorsomedial hypothalamus 
DTJ: diencephalic-telencephalic junction 
DV: dorso-ventral 
E[x]: embryonic date [x] in mouse 
HH: Hamburger-Hamilton developmental stage in chick 
ID: intrahypothalamic diagonal 
LH: lateral hypothalamus 
MM: medial mammillary 
p[x]: prosomere x 
PCP: prechordal plate 
PeVN: periventricular nucleus 
PH=posterior hypothalamus 
PMN: premammillary nucleus 
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POA: preoptic area 
PrTH: prethalamus 
PVN: paraventricular nucleus 
SON: supraoptic nucleus 
SCN: suprachiasmatic nucleus 
SMM: supramammillary nucleus 
TH: tuberal hypothalamus 
TT: tuberomammillary terminal 
vAH: ventral anterior hypothalamus 
VMH: ventromedial hypothalamus 
ZI: zona incerta 
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The hypothalamus controls a wide range of homeostatic processes essential for life, 
including feeding, thirst, sleep, circadian rhythms, reproductive behavior, and more.  
This brain region, derived from the rostral diencephalon of the forebrain, is 
enormously anatomically complex.  Where other brain regions like the cortex or 
hippocampus have a clear overall structure of columns and parallel feed-forward 
loops, respectively, the hypothalamus has a densely interconnected patchwork of often 
quite ill-defined nuclei.  Partially for this reason, the study of hypothalamic 
development has lagged behind that of many other brain regions, whose simpler 
                                                          




anatomy facilitated the identification of factors that pattern them.  However, as 
determinants of hypothalamic identity were studied in recent years, it has become 
increasingly clear that many of the same factors implicated in development of the 
cortex, retina and other CNS regions play similar roles in the hypothalamus.  
Shortly after the neural plate forms following gastrulation, diffusible 
morphogens begin patterning the developing nervous system, including the 
hypothalamus.  In the beginning, these factors are generated outside of neural tissues, 
in mesodermal domains including the axial notochord and more anterior prechordal 
plate (PCP), as well as other more lateral tissues.  Often, production of these same 
cues is later induced in neural tissue near or within the nascent hypothalamus, where 
dynamically shifting sources of morphogen production create ever-finer concentration 
gradients within the region.  Sharp boundaries are translated from these gradients 
through induction of distinct and often mutually repressive sets of cell-autonomous 
transcription factors, progressively defining the fate of neural progenitors and 
emerging hypothalamic nuclei (Wilson and Houart, 2004; Hoch et al., 2009).   
 
1.1 HYPOTHALAMIC INDUCTION AND SPATIAL PATTERNING 
 




The Wnts are a large family of secreted, lipid-modified glycoproteins long known to 
be involved in patterning during development, having originally been implicated in 
developmental segmentation by their homology to the Drosophila Wingless gene.  
Anterior-posterior (AP) patterning of newly induced neural plate is initiated by the 
posteriorizing morphogen Wnt8, secreted by lateral mesodermal precursors.  Its effect 
is enhanced and sustained by nodal signaling in the posterior neural plate.  Conversely, 
Wnt inhibition is necessary for anterior patterning, including the region that eventually 
gives rise to the hypothalamus.  A variety of Wnt inhibitors are expressed in spatially 
and temporally dynamic patterns, first in the PCP (Figure 1) and later in the developing 
anterior brain.  These inhibitors include sFRP1, sFRP2, sFRP3/Frzb1, 
Crescent/Frzb2, Dickkopf1 and Cerberus (Chapman et al., 2004; Erter et al., 2001).   
After initial AP patterning, Wnt signaling in turn subdivides the forebrain.  The 
domain receiving lower Wnt signaling gives rise to the telencephalon, which includes 
the cerebral cortex, hippocampus, striatum, amygdala and associated structures.  
Higher Wnt signaling induces development of the diencephalon, including a more 
rostral domain that gives rise to the hypothalamus and prethalamus, and a more caudal 
domain that gives rise to the thalamus (Chatterjee and Li, 2012).  Telencephalic and 
rostral diencephalic neuroepithelium are hereafter distinguished by expression of the 
forkhead domain transcription factors FOXG1 and FOXD1, respectively (Hatini et 
al., 1994; Shimogori et al., 2010).   
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However, despite relatively high Wnt signaling in the diencephalon early on, 
inhibition of canonical Wnt signaling by Axin1 is essential for initial hypothalamic 
specification.  In Axin1-/- mice, the ventral midline cells of the hypothalamus fail to 
develop, instead assuming a caudal floor plate identity (Kapsimali et al., 2004).  Later 
roles of Wnts in hypothalamic development explain this seeming paradox.  During the 
late gastrula stage in zebrafish, Wnt8b and Wnt1 secreted from the midbrain-hindbrain 
boundary pattern the forebrain and induce specification of posterior diencephalon, 
including the sensory thalamus and habenula.  Overexpression of these Wnts or their 
receptors, or loss of the Wnt inhibitor Axin1, induce expanded expression of posterior 
hypothalamic markers such as Emx2 at the expense of anterotuberal hypothalamic 
markers such as Rx3, suggesting a posteriorization of hypothalamic neuroepithelium 
(Kapsimali et al., 2004; Kim et al., 2002).   
 Consistent with this finding, Wnt8b is expressed in the mouse posterior 
hypothalamus beginning at ~E8.5 (Shimogori et al., 2010; Garda et al., 2002), 
consistent with a role in patterning, but its function has not been directly explored in 
this context (Figure 2E).  By E12.5, Wnt8b becomes restricted to the mammillary 
region, suggesting it may act to impart posterior hypothalamic identity in mammals as 
it does in zebrafish (Shimogori et al., 2010) (Figure 2F).  WNT7a/7b become 
expressed selectively in prethalamic and hypothalamic GABAergic neuronal 
progenitors around the same time, suggesting a role in interneuron development, but 
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their function is even less well characterized than WNT8b (Shimogori et al., 2010) 
(Figure 2F).   
 Meanwhile, a gradient of WNT3 signaling further patterns the developing 
forebrain, including the hypothalamus (Figure 2F).  High levels of WNT3 induce Irx3 
expression in the sensory thalamus, while low WNT3 signaling is permissive for more 
anterior Six3 expression in the hypothalamus and prethalamus (Braun et al., 2003).  
Mutual cross-repression of SIX3 and IRX3 demarcates the border between these 
regions, an effect that is reinforced by SIX3-mediated dampening of WNT 
responsiveness.  Confirming the importance of these interactions, Six3-/- mice show a 
rostral expansion of caudal diencephalic markers at the expense of the hypothalamus 
and telencephalon, largely due to an anterior expansion of WNT1 expression in the 
roof plate of the forebrain (Wilson and Houart, 2004; Lagutin et al., 2003).  
 
1.1.2 Sonic Hedgehog (SHH) Signaling 
 
Concurrent with Wnts’ central role in early AP patterning of the developing neural 
tube, the lipid-linked polypeptide signal SHH is a key secreted morphogen controlling 
neural dorso-ventral (DV) patterning.   SHH is first expressed in the PCP (Figure 1), 
and is necessary for initial induction of the hypothalamus (Chiang et al., 1996; Mathieu 
et al., 2002). The ventral midline cells initially have a quasi-caudal floor plate identity, 
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including expression of HNF3β but not the floor plate markers FP3 and FP4 (Dale et 
al, 1997) (Figure 1).   PCP-derived SHH goes on to induce transient Shh expression in 
the ventral diencephalic midline (and much of the rest of the developing 
hypothalamus) through a GLI-mediated signaling cascade that activates expression of 
transcription factors including SIX3, SOX2, and SOX3 (Braun et al., 2003; Zhao et 
al., 2012). SOX2 and SOX3, members of the SOXB1 transcription factor family, 
directly activate and maintain Shh transcription in hypothalamic neuroepithelium 
(Zhao et al., 2012).   SIX3 likewise targets the Shh brain enhancer-2 to directly activate 
Shh transcription there (Geng et al., 2008; Jeong et al., 2008).   
A subsequent down-regulation of Shh expression is important for 
hypothalamic patterning.  Indeed, early patterning of the ventral hypothalamus along 
the AP axis is achieved in part through down-regulation of Shh expression in ventral 
tuberomammillary hypothalamus (Mathieu et al., 2002; Ohyama et al., 2008; Manning 
et al., 2006) (Figure 2B).  For instance, studies in chick demonstrate cells giving rise to 
this region must down-regulate Shh to adopt their proper fate through induction of 
Tbx2 expression, which in turn triggers Shh downregulation by upregulation of Bmp7 
in the tuberomammillary hypothalamic neuroepithelium (see next section).   
In contrast to the ventral tuberomammillary hypothalamus, Shh expression in 
the basal plate, which is initially induced by PCP Shh and additional feed-forward Shh 
signaling from the ventral midline, is maintained through E14.5 (Zeltser 2005; Vieira 
and Martinez, 2006) (Figure 2B-D).  This more dorsally located hypothalamic region 
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begins immediately posterior and ventral to the presumptive suprachiasmatic nucleus 
(SCN) and terminates in the mammillary region (Shimogori et al., 2010; Alvarez-
Bolado et al., 2012) (Figure 2B-D).  Shh-positive cells of the basal plate originate at the 
diencephalic/mesencephalic border, then migrate to their final destination in the 
hypothalamus (Manning et al., 2006).  Basal plate SHH plays a critical role in 
hypothalamic patterning.  Several studies have looked at loss of function mutants in 
which Shh is deleted from the basal plate.  In these studies, the hypothalamus is still 
specified, but neurons fail to undergo further differentiation, resulting in the loss or 
reduction of several nuclear markers.  In all mutant lines examined, both AP and DV 
patterning is disrupted, although the reported phenotypes are not identical among 
these studies, most likely because they used Cre-drivers with different spatial and 
temporal patterns of activity (Shimogori et al., 2010; Zhao et al., 2012; Szabo et al., 
2009; Blackshaw et al., 2010).   
Basal plate Shh is also necessary to initiate sustained Shh expression in the 
zona limitans incerta (ZLI), a secondary Shh-positive organizer dividing the 
prethalamus and thalamus (Beccari et al., 2013; Scholpp et al., 2006). ZLI-derived Shh 
plays a central role in patterning the sensory thalamus, and is required for proliferation 
and differentiation of prethalamic progenitors (Zeltser, 2005; Vieira and Martinez, 
2006; Vieira et al., 2010) (Figure 2B-D).  Importantly, ZLI Shh expression is preserved 
in Cre/lox studies where Shh was deleted in the basal plate, showing that the 




1.1.3 Bone-Morphogenetic Protein (Bmp) Signaling 
 
BMP7 is the primary member of this family of TGF-beta superfamily members that 
has been studied in the context of hypothalamic development.  Surprisingly given the 
classical physical separation and antagonistic effects of BMPs and SHH in spinal DV 
patterning, many known actions of BMP7 in the hypothalamus revolve around 
cooperative interactions with SHH.  For instance, during gastrulation, PCP-derived 
BMP7 and SHH cooperate to induce expression of early general hypothalamic markers 
such as Nkx2.1 in the ventral diencephalic midline, distinct from more caudal midline 
gene expression induced by notochord-derived SHH alone (Figure 1) (Dale et al., 
1997). 
   During later stages of hypothalamic patterning, both Bmp7 and Shh are 
transiently coexpressed in ventral tuberomammillary hypothalamus (Manning et al., 
2006) (Figure 1).  BMP7 swiftly down-regulates Shh expression here by activating 
expression of first Tbx2 and subsequently Gli3, although it’s unclear if TBX2 directly 
activates Gli3 expression (Ohyama et al., 2008; Manning et al., 2006).  In chick this 
process begins around Hamburger and Hamilton (HH) stage 10, inducing complete 
elimination of Shh by HH stage 16 (roughly equivalent to E9.5-10.5 in mouse) 
(Alvarez-Bolado et al., 2012).   Tbx2 itself is in turn down-regulated during stages 16-
22; toward the end of this period, ventral tuberomammillary markers such as Fgf10 
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and Emx2 begin to be expressed in these now Shh-negative subdomains of the 
developing hypothalamus.   
 BMP7 signaling is also required for induction of Pax7 expression in more 
dorsally located tuberomammillary progenitors, which occurs by HH stage 30.  BMP7 
accomplishes this by both down-regulating Shh expression in ventral 
tuberomammillary hypothalamus, and by directly activating Pax7 transcription via 
induction of Smad5 phosphorylation (Ohyama et al., 2008).  Interestingly, widespread 
expression of the Bmp antagonist Chrdl1 is detected in chick hypothalamus at HH 
stage 13, with expression restricted to the anterioventral hypothalamic 
neuroepithelium by HH15 as Bmp expression becomes restricted to posterioventral 
hypothalamus.  Chrdl1 expression is upregulated in response to inhibition of Notch 
signaling, suggesting that Notch may play a role in early hypothalamic development by 
modulating BMP signaling (Ratié et al., 2013), although this has not yet been shown 
directly.     
 
1.1.4 Nodal Signaling 
 
Nodal proteins are other members of the TGF beta superfamily that play an important 
role in hypothalamic patterning.  PCP-derived Nodal signaling, most notably by 
cyclops, plays an essential role in initial hypothalamic specification in zebrafish 
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(Machluf et al., 2011) (Figure 1).  Together with Shh and Bmp7, nodal signaling is 
essential for induction of early hypothalamic markers such as Nkx2.1; however, unlike 
in the telencephalon, Shh is not able to restore initial expression of the Nkx2.1 
homolog in zebrafish diencephalon in the absence of nodal, suggesting a separable 
role for nodal in early hypothalamic induction (Rohr et al., 2001).   
On the other hand, cells defective in both Nodal and Shh signaling are unable 
to give rise to hypothalamic cells following transplantation into wildtype zebrafish, and 
Shh can restore some nkx2.1 expression in the zebrafish ventral posterior 
hypothalamus (vPH) during early stages of hypothalamic development (Mathieu et al., 
2002; Rohr et al., 2001).  Together, these data suggest a cooperative role for Nodal and 
Shh in later stages of hypothalamic development, with Nodal enhancing the ability of 
cells to respond to Shh.    
 There also appears to be cross-talk between Nodals and Wnts in hypothalamic 
development, as the Wnt inhibitor Axin1 facilitates Nodal signaling (Kapsimali et al., 
2004).  Axin1 may thus alter the competence of hypothalamic progenitors to respond 
to both Nodal and indirectly, to Shh signaling, likely explaining the non-cell-
autonomous requirement for Nodal signaling in patterning of the dorsal anterior 
hypothalamus (dAH) by Shh (Mathieu et al., 2002).  Conversely, cells of the zebrafish 
vPH require Nodal signaling cell-autonomously in order to activate emx2 expression, 
while excessive Shh signaling inhibits emx2 expression.  Thus, Nodal must cooperate 
with Bmp7 to induce emx2 in vPH—while Nodal acts as a cell-autonomous factor 
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conferring competence to activate emx2 expression, Bmp7 inhibits local shh to prevent 
Shh signaling from becoming excessive.  Thus, Axin1 sits at the nexus of Wnt, Shh, 
Nodal, and Bmp signaling, from which it serves as a critical, integrative determinant 
of anterior-posterior identity.     
 
1.1.5 Fibroblast Growth Factor (FGF) Signaling 
 
FGF family members do not appear to play a critical role in early stages of 
hypothalamic patterning.  Irx3 is required for competence to respond to Fgf8 
signaling, but is excluded from the hypothalamus during this time by its cross-
repressive interaction with Six3. The ZLI lies between the Six3-positive rostral 
diencephalon and Irx3-positive caudal diencephalon, demarcating the boundary of 
competence to Fgf8 signaling from the isthmic organizer and telencephalic roof plate 
(Kobayashi et al., 2002).  That said, FGF family members do regulate cell proliferation 
at later stages of hypothalamic development.   
 




Hypothalamic neurogenesis occurs from ~E10.5-16.5 in mice, with the great majority 
of hypothalamic neurons being generated between E12.5 and E14.5 (Ratié et al., 2013; 
Byerly and Blackshaw, 2009; Shimada and Nakamura, 1973).  Birthdating studies using 
tritiated thymidine and BrdU indicated that neurons in lateral hypothalamic nuclei are 
typically born before medial nuclei, resulting in an “outside-in” pattern of birth in the 
hypothalamus (Shimada and Nakamura, 1973).  However, later research has 
contradicted this model.  Looking at different parvocellular neuronal cell types within 
the neurosecretory dorsolateral anterior hypothalamus (dlAH), all were found to be 
born during the same approximate interval, despite occupying different medial-lateral 
locations within the hypothalamus (Markakis and Swanson, 1997).  Similar results have 
been reported for different neuronal subtypes in the arcuate nucleus (ARC) (Padilla et 
al., 2010), suggesting that for progenitors in at least some regions of the hypothalamus, 
this “outside-in” order of cell generation may not hold.   
 Growth and differentiation factors that pattern the developing hypothalamus 
also play important roles in later stages of hypothalamic cell fate specification. For 
example, while SHH is required for both early and late neurogenesis in much of the 
hypothalamus (Shimogori et al., 2010; Ishibashi and McMahon, 2002), Shh down-
regulation is necessary for proliferation and expansion of the ventral 
tuberomammillary progenitor pool (Manning et al, 2006).  Meanwhile, canonical Wnt 
signaling, through its effector Lef1, plays an important role in both progenitor 
maintenance and in driving progenitor differentiation in the posterior hypothalamus 
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(Lee et al., 2006; Wang et al., 2009).  Notch signaling is also involved in progenitor 
maintenance in the hypothalamus, as it is elsewhere in the developing nervous system, 
but the specifics of its role in different parts of the hypothalamus has only recently 
begun to be understood (Ratié et al., 2013; Aujla et al., 2013).  In the rostral 
hypothalamus, Notch signaling works through lateral inhibition to regulate the 
progenitor population and generate new neurons.  High levels of Notch signaling in 
AH upregulate Hes and Hey family genes, while downregulating proneural genes such 
as Ascl1 and Nhlh1. The genes Tagln3, Chga, Robo2, Slit1, and Chrdl1 are then needed 
for terminal neural differentiation once precursor cells have exited mitosis.    
 Expression of a diverse assortment of transcription factors are induced by the 
intricate spatiotemporal code of exposure to morphogens discussed previously, which 
in turn confer intrinsic spatial identity upon hypothalamic progenitor cells.  Patterning 
processes establish the anatomical DV and AP axes within the hypothalamus, limiting 
which nuclei can develop at any given set of coordinates.  Consequently, many markers 
ubiquitously expressed in early hypothalamic progenitors become more restricted once 
neurogenesis begins.  For instance, Six3 and Lhx2 are expressed in the anterior and 
tuberal hypothalamus (AH and TH), but not the PH.  Meanwhile, Rax and Nkx2.1 are 
expressed in the TH and PH, but only in limited regions of the AH (http://www.brain-
map.org).   
   However, these still relatively broad domains of transcription factor expression 
become even more regionalized as neurogenesis progresses.  Continuing with the 
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previous examples, Lhx2 becomes restricted to the dorsolateral aspects of AH (dlAH) 
while Six3 becomes restricted to the ventral AH (vAH).  Meanwhile, Rax expression 
is rapidly downregulated everywhere except the ventral TH, though Nkx2.1 remains 
comparatively broadly expressed in the TH and PH (Shimogori et al., 2010; 
http://www.brain-map.org; Lu et al., 2013; Roy et al., 2013; VanDunk et al., 2011).  
By mouse E12.5, progressive restriction of expression of these and assorted other 
genes has already defined many nuclei found in the adult hypothalamus (Figure 3).  
 Developmental expression of over a thousand such mouse genes were 
documented in an extensive screen published by Shimogori et al. in 2010.  Among 
other findings, this study identified the intrahypothalamic diagonal/tuberomammillary 
terminal (ID/TT) complex, an excellent example of progressive regionalization in the 
hypothalamus.  This region traverses most of the hypothalamus in the sagittal plane 
starting at E12.5 (Figure 3) and is characterized by uniform expression of Arx and 
patterned expression of Lim homeodomain factors Lhx1, Lhx6, Lhx8, and Lhx9.  This 
largely non-overlapping pattern of LIM homeodomain factor expression appears to 
define a number of hypothalamic nuclei involved in control of circadian rhythms and 
sleep homeostasis, such as the SCN, DMH, and parts of the LH (Figure 4).  In at least 
two cases, these genes are required for proper development of the hypothalamic cell 
types in which they are expressed (Bedont et al., 2014; Dalal et al., 2013). Such findings 
have already begun to facilitate the study of the development of individual 





Figure 1-1:  Schematic showing the inductive signals that act on the ventral 
neural plate.  The posterior neural plate receives inductive signals from the notochord 
to become floor plate, whereas the more anterior neural plate that goes on to become 
the hypothalamus receives a different set of inductive signals from the prechordal 
plate. Circles represent signaling from the prechordal plate/notochord, whereas the 
Figure 1-1. Schematic showing the inductive signals that act on the ventral neural plate.  
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diagonal bars in the neural plate represent local gene expression. It should be noted 
that the juxtaposition of the prechordal plate and the hypothalamic neural plate is 
transient. These structures migrate out of register with each other. The prechordal 
plate reaches its final rostral position in advance of the hypothalamic neural plate, 
which migrates over and rostrally past the prechordal plate. Thus by the time the floor 
plate and the hypothalamic neural plate are specified, the prechordal plate actually 





Figure 1-2. Sagittal view of morphogen expression over the course of development in the 
mouse forebrain, emphasizing the hypothalamus.  
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Figure 1-2:  Sagittal view of morphogen expression over the course of 
development in the mouse forebrain, emphasizing the hypothalamus. (a–c). 
Forebrain Shh expression from E8.5 through E11.5. (d). Hypothalamic Shh expression 
at E12.5. White bars represent areas of diffuse Shhexpression. (e) Wnt expression in 
the forebrain at E9.5. (f). Wnt expression in the hypothalamus at E12.5. Wnt 7a/7b is 
expressed in interneuron progenitors only while Wnt 3/3a and Wnt 8a/8b are 
expressed more broadly. BP, basal plate; ZLI, zona limitans intrathalamica; POA, 




Figure 1-3. Sagittal map of nuclei in the mouse hypothalamus at E12.5 at the level of the third ventricle.  
Figure 1-3:  Sagittal map of nuclei in the mouse hypothalamus at E12.5 at the 
level of the third ventricle. ZLI, zona limitans intrathalamica; PreThal, prethalamus; 
EmThal, thalamic eminence; PVN, paraventricular nucleus; vAH, ventral anterior 
hypothalamus; ant. ID, anterior intrahypothalamic diagonal; ID, intrahypothalamic 
diagonal; ARC, arcuate nucleus; VMH, ventromedial hypothalamus; PMN, 
premammillary nucleus; TT, tuberomammillary terminal; MMN, mammillary nucleus; 




Figure 1-4. Coronal diagrams of the nuclei of the developing hypothalamus at ∼E15.5. 
Figure 1-4:  (a-d): Coronal diagrams of the nuclei of the developing 
hypothalamus at ∼E15.5.  Insets in the upper right-hand corners indicate the 
approximate position of these coronal sections in the sagittal plane. Note that the angle 
of the cut shown in the developing hypothalamus sometimes places nuclei normally 
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present on different coronal planes in typical adult brain sections on the same plane in 
our diagram (e.g.: SCN and DMH in panel b). SCN, suprachiasmatic nucleus; DMH, 
dorsomedial hypothalamic; PVN, paraventricular nucleus; AH, anterior hypothalamus; 














2.1.1 Foxd1 Expression in the Hypothalamus 
 
Previous work from our lab has shown that the Forkhead domain transcription factor 
Foxd1 is expressed in the ventricular zone of the prethalamus and anterior and dorsal 
hypothalamus by E11.5, shows reduced expression thereafter, and is almost 
undetectable by E14.5 except for a small domain near the 3rd ventricle in the 
prethalamus (Shimogori et al, 2010).  Further characterization and fate-mapping of 
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this gene by our lab showed broad and efficient labeling of cells throughout the 
prethalamus and hypothalamus in adult mice using a Cre-induced GFP reporter line 
(Salvatierra et al., 2014).  Foxd1 is known to be involved in the development of the 
kidneys (Hatini et al., 1996), retina (Carreres et al., 2011), and optic chiasm (Herrera et 
al., 2004) and is a close homolog of, and cross-inhibitory with, Foxg1, which is known 
to control the competence of cortical progenitors (Siegenthaler et al., 2008).  Nothing 
is known about the role of Foxd1 in the development of the diencephalon, but given 
its broad expression throughout the hypothalamus and prethalamus, it may potentially 
play an important role in the patterning of these structures.   
 
2.1.2 Foxd1 is Expressed Early and Broadly in Neural Progenitors of the 
Prethalamus and Hypothalamus 
 
Although previous research had shown that Foxd1 is expressed broadly in 
hypothalamic and prethalamic progenitors, it was not yet known when Foxd1 is first 
turned on in the presumptive diencephalon.  To determine this, we employed mice in 
which a Cre-GFP fusion has been inserted into the endogenous Foxd1 locus, 
simultaneously disrupting expression of Foxd1 (these mice are hereafter referred to as 
Foxd1-Cre mice).  We then crossed these mice to an Ai9 reporter line in which 
expression of Tdtomato (under the control of a constitutively active Rosa26 promoter) 
is activated by Foxd1-Cre.  In these mice, green cells are currently expressing the Foxd1-
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Cre while red cells have expressed the Foxd1-Cre at some point in their lineage.  Analysis 
of TdTomato expression in an E8.5 Foxd1-Cre+/-; Ai9 mouse embryo revealed strong 
expression in the ventral forebrain (white arrowheads, Figure 1A).  Therefore, Foxd1 
is expressed at least as early as E8.5 in the presumptive hypothalamus and prethalamus.  
Whole-mount in situ hybridization against Foxd1 mRNA at E9.0 (Figure 1C) and E10.0 
(Figure 1D) revealed strong expression in the hypothalamus and prethalamus at both 
ages (white arrowheads, Figure 1 C, D).  By E12.5, Foxd1 expression is limited to the 
ventricular zone of the prethalamus and anterior hypothalamus (AH), as revealed by 
immunohistochemistry against GFP in a Foxd1-Cre+/- embryo.  However, staining for 
TdTomato in an E12.5 Foxd1-Cre+/-; Ai9 mouse embryo revealed widespread staining 
throughout the entire hypothalamus (white arrowheads, Figure 1F) and prethalamus 
(open arrowheads, Figure 1F) at E12.5 (left panel shows efferent and afferent 
connections).  This was further confirmed by analyzing the Foxd1-Cre+/-; Ai9 mouse at 
P0, which labelled all mature nuclei and areas of the hypothalamus and prethalamus 
(open arrowheads=prethalamus, white arrowheads=SCN, Figure 1D).   
 
2.1.3 Loss of Foxd1 Leads to a Disruption in Development of the Anterior 
Hypothalamus by P0 
 
We generated a Foxd1-null animal by crossing Foxd1-Cre+/- animals to generate Foxd1-
Cre+/+ pups (hereafter referred to as Foxd1-/- mice).  The Cre used is a knock-in that 
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disrupts transcription of the endogenous Foxd1 but operates under the control of the 
Foxd1 promoter (Humphreys et al., 2008).  Foxd1-null mutants die within 24 hrs of 
birth as shown in previous studies of these animals (Hatini et al., 1996) so the latest 
time point analyzed was P0.  It is not known exactly why these mutants die, but may 
be related to the fact that Foxd1-deficient animals show severe defects in kidney 
development and function.    
 We analyzed Foxd1-/- mice at P0 using in situ hybridization and ran a large panel 
of probes to determine which areas of the prethalamus and hypothalamus, if any, 
would be affected by the loss of Foxd1 during development.  Surprisingly, the only 
major defect seen was in the nuclei of the anterior hypothalamus.  The suprachiasmatic 
nucleus (SCN) showed a reduction, or in some cases complete loss, in the majority of 
probes tested.  The nuclear markers Lhx1 and Vipr2 were completely absent in the 
Foxd1-null mutants (Figure 2 E, F, K, and L).  Other nuclear markers were significantly 
reduced, including Avp (Figure 2 A and B), Rorb (Figure 2 G and H), Emx2 (Figure 2 
M and N), and Rora (Figure 2 Q and R).  Surprisingly, Gad67 expression appeared to 
be normal in the SCN of the Foxd1-/- mice (Figure 2 C and D), and Th and Trh, which 
are expressed in cells bordering the SCN but not within it, were normal as well (Figure 
2 I, J, U and V).  In wild-type mice, the SCN is easily detectable using DAPI staining 
as a cell-dense tear-drop shaped nucleus on the ventral surface of the anterior 
hypothalamus (Figure 2W).  In most Foxd1-/- mice examined, the SCN could not be 
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identified using DAPI staining (data not shown).  Less commonly, the SCN appeared 
as a large, diffuse, poorly defined area (Figure 2 X).  
The loss of Foxd1 affected other nuclei of the anterior hypothalamus as well.  
The paraventricular nucleus (PVN) was disrupted, as demonstrated by the reduction 
in Avp expression (black arrowheads, Figure 2 A and B) and complete loss of Sst 
expression (black arrowhead, Figure 2 S and T).  However, Trh expression was normal 
within the PVN (black arrowhead, Figure 4 I and J). Sst expression was also completely 
absent in the periventricular nucleus (PeVN) (open arrowheads, Figure 2 S and T), 
along with Emx2, which is expressed in a small domain of the anteroventral 
hypothalamus (black arrowhead, Figure 2 M and N).  Expression of Isl1, which is 
broadly expressed in the anterior and tuberal hypothalamus, was also reduced but not 
absent (Figure 2 O and P).  The results of the anterior hypothalamic defect are 
summarized in Figure 3.   
Given the dramatic loss of anterior hypothalamic markers, we wanted to 
determine if loss of Foxd1 affected progenitor proliferation or cell apoptosis, leading 
to a loss of these cells.  A 2hr EdU pulse was given to pregnant dams on E12.5, and 
EdU-positive cells within the prethalamus and hypothalamus were counted, but there 
was no effect seen on numbers of proliferating cells in Foxd1-/- mice when averaged 
relative to area (µm2) (Figure 5 A-C; n=2 mice).  There was also no change seen in a 
TUNEL assay of cell death in Foxd1-/- mice (data not shown).      
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Foxd1 expression persists longest in progenitors of the anterior hypothalamus 
and the prethalamus, but surprisingly despite the severe disruption of the development 
of the anterior hypothalamus, there were no discernible defects in the prethalamus.  
Isl1 and Sst, whose expression patterns were disrupted in the anterior hypothalamus in 
Foxd1-/- mice, showed unaltered expression in the prethalamus (red arrowheads, Figure 
2 O, P, S and T).   
In contrast to the strong defect seen in the anterior hypothalamus in Foxd1-/- 
mice, the lateral and posterior hypothalamus developed relatively normally.  Emx2 and 
Foxb1 expression were unaffected in the mammillary body (black arrowheads, Figure 
4 A and B; data not shown).  Markers of the arcuate nucleus (Arc) developed normally 
as well, including Th (black arrowheads, Figure 4 G and H), Sst (open arrowheads, 
Figure 4 E and F), Npy and Cart (data not shown).  The same was true of the 
dorsomedial hypothalamus (DMH) (Sst: black arrowheads, Figure 4 E and F; Trh: black 
arrowheads; Figure 4 K and L, Cart: data not shown), and the lateral hypothalamus 
(LH) (Trh: open arrowheads; Figure 4 I-L).  Sst expression in the tuberomammillary 
(red arrowheads, Figure 4 E and F), and in the border between the DMH and 
ventromedial hypothalamus (VMH) (yellow arrowheads, Figure 4 E and F) was 
unaffected.  Similarly, Trh in the supraoptic nucleus (SON) (red arrowheads, Figure 4 
I and J) showed no change in the Foxd1-null mutants.  One notable exception was the 
marker Isl1, whose expression in the DMH (open arrowheads, Figure 4 C and D), 
arcuate (red arrowheads, Figure 4 C and D) and ventrolateral ventromedial 
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hypothalamus (VMH) (yellow arrowheads, Figure 4 C and D) was completely absent 
in the Foxd1-null mutants, with only a small remnant remaining in the most medial 
portion of its LH domain (black arrowheads, Figure 4 C and D).  This may be due to 
inefficient staining during the in situ hybridization, but strong staining in the 
prethalamus (red arrowhead, Figure 2 P) suggests against this theory.   
 
2.1.4 Foxd1-/- Mice Have a Mild Developmental Defect at E12.5 and E16.5 
 
There were two possible scenarios for the developmental dynamics of the disrupted 
anterior hypothalamus in our mutants: either the anterior hypothalamus failed to be 
specified early in development, or the anterior hypothalamus was specified correctly, 
but failed to turn-on and/or maintain expression of the markers of the mature nuclei.  
To determine which scenario was occurring, we examined Foxd1-/- embryos at two 
stages of development: E12.5, coinciding with the onset of the earliest markers of the 
anterior hypothalamus, and E16.5 when the first SCN-specific markers are turned on.   
At E12.5, ventral anterior hypothalamic markers Isl1 (open arrowheads, Figure 
6 B and C) and Rax (Figure 6 D and E) were normal in Foxd1-/- mice.  Isl1 expression 
was also normal within the prethalamus (Figure 6 B and C).  Arx, which is expressed 
in a stripe from the prethalamus through the hypothalamus, was expressed normally 
in both regions (black arrows: prethalamus, open arrow: hypothalamus, Figure 6 H 
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and I).  One of the earliest markers of the PVN, Sim1, was similarly normal (Figure 6 
L and M).  Importantly, Lhx1, which is completely absent by P0 in the SCN of Foxd1-
/- mice, was not affected at E12.5 in either the anterior hypothalamus (open 
arrowheads, Figure 6 J and K) or the prethalamus (black arrowheads, Figure 6 J and 
K).  However the Foxd1-/- mice did not phenocopy wild-type embryos with all markers 
tested.  Both Six3 (open arrowheads, Figure 6 F and G) and Vax1 (open arrowheads, 
Figure 6 N and O) showed moderate-to-strong reductions in the ventral anterior 
hypothalamus.  In addition, the central nuclear portion of Six3 staining in the 
prethalamus was absent in Foxd1-/- mice (black and red arrowheads, indicating the 
prethalamus and missing expression domain, respectively, Figure 6 F and G).    
By E16.5, Lhx1, which in Foxd1-/- mice was present and normal at E12.5 and 
absent at P0, was present but mildly reduced in the SCN (Figure 7 E and F).  Similarly, 
Rorb, which was strongly reduced by P0, was mildly reduced in the SCN at E16.5 
(Figure 7 C and D).  Sst expression is not yet initiated in the PeVN at E16.5 (Figure 7 
G and H) and Isl1 expression was normal in the anterior hypothalamus (Figure 7 A 
and B).   
 To determine which genes may be under the transcriptional control of Foxd1, 
RNAseq analysis was performed on RNA extracted from dissected hypothalamic 
tissue at E12.0, E12.5 and E17.5.  The E12.0 and E12.5 data were pooled together for 
analysis.  Genes with a q-value of <0.05 were considered significant.  The statistically 
significant differentially expressed genes are listed in Table 1 (E17.5 data) and Table 2 
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(E12.0 and E12.5 pooled data).  In both data sets, Foxd1 was the most significantly 
downregulated gene, as expected.  Gene ontology (GO) analysis was performed on 
the statistically significant genes in order to group them within three domains: 
biological processes (Figure 8), cellular compartments (Figure 9) and molecular 
function (Figure 10).  The genes included in each category within each domain are 
summarized in Table 3 (E12.0/E12.5 genes), Table 4 (E17.5 data for cellular 
compartments and molecular function) and Table 5 (E17.5 data for biological 
processes).   
 At E12.0/E12.5, one of the significantly downregulated genes was Six3, which 
is confirmed by the E12.5 in situ hybridization data; Six3 was one of only two genes 
whose expression was lower in Foxd1-/- mice  at E12.5 (Figure 6 F and G).  The other 
downregulated gene at E12.5 was Vax1, which did not reach significance in the 
E12.0/E12.5 RNA-Seq data, but was significantly downregulated in the E17.5 RNA-
seq data set.  At E17.5, there were several other anterior hypothalamic genes which 
were significantly downregulated, including Avp, which was also confirmed by our P0 
in situ hybridization data (Figure 2 A and B), as well as Crh (expressed in the PVN), 
Zbtb18 (in the ventral AH), Cdh23 (AH), Neurod6 (ventral AH), Slc6a3 (AH and zona 
incerta (ZI)), Oxt (PVN), 4930555G01Rik (AH), and Moxd1 (BNST and POA). 
 There were several genes enriched in the E17.5 RNA-Seq data set that likely 
represent dissection contaminants (Table 1), most originating from telencephalon and 
habenula, including Tbr1, Foxg1, Irx1, Neurod2, Pou4f1, and Satb2.  There were also 
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contaminants from the choroid plexus (Ttr), and meninges (Dcn, although Foxd1 is 
also expressed in the meninges).  Ddx3y and Eif2s3y are Y chromosomal genes, and 
their inclusion is likely an artifact resulting from the fact that we did not sex the 
embryos used for the hypothalamic dissection.  The female sex-specific gene Xist was 




Figure 2-1. The Foxd1 lineage encompasses every cell of the hypothalamus and prethalamus, and its 




Figure 2-1:  The Foxd1 lineage encompasses every cell of the hypothalamus and 
prethalamus, and its expression is turned on early.  A:  Endogenous staining from 
a Foxd1-Cre+/-; Ai9 E8.5 embryo.  White arrowheads indicate the presumptive 
hypothalamus in the ventral neural tube.  B, C:  Whole mount in situ hybridization of 
Foxd1 mRNA at E9.0 (B) and E10.0 (C).  The hypothalamus is designated by the 
white arrowheads.  D:  Lineage tracing via immunohistochemistry staining against 
dsRed in a Foxd1-cre+/-; Ai9, P0 brain.  Red cells have expressed Foxd1-cre at some 
point in their lineage.  Blue=DAPI.  Open arrowheads=prethalamus, white 
arrowheads=SCN.  Anterior to posterior goes from left to right and top to 
bottom.  E:  Immunohistochemistry staining against GFP in a Foxd1-cre+/-:GFP E12.5 
brain.  By this age, Foxd1 is expressed only in the prethalamus (open arrowhead) and 
the anterior hypothalamus (white arrowhead) along the ventricle.  F.  Despite the 
limited Foxd1 expression at E12.5, lineage tracing in an E12.5 Foxd1-Cre+/-; Ai9 brain 
reveals that every cell in the hypothalamus and prethalamus originates from a Foxd1-








Figure 2-2:  Loss of Foxd1 results in a selective loss of anterior hypothalamic 
markers at P0.  A-V: In situ hybridization of P0 wild-type and Foxd1-/- coronal brain 
sections.  There was either a complete loss, or a strong reduction, in markers of the 
SCN (open arrowheads, A-N, Q, R).  However, there were exceptions, including 
Gad67 (open arrowheads, C, D) and the markers Th and Trh (open arrowheads, I, J, 
U, V), which are not expressed in the SCN proper, but rather the cells that border 
it.  Markers of the PVN were also negatively affected by the loss of Foxd1 (black 
arrowheads, A, B, S, T), as was Sst in the PeVN (open arrowheads, S, T).   The general 
anterior hypothalamic marker Isl1 was also strongly reduced (open arrowheads, O, 
P.  The prethalamus was unaffected, despite strong Foxd1 expression in this area (red 
arrowheads, O, P, S, T).  W, X: The SCN is normally identified as a tear-drop shaped, 
dense nucleus (red dashed outline, W) but in some Foxd1-/- brains, it presented as a 





Figure 2-3. A schematic summarizing the developmental defects in the anterior hypothalamus of Foxd1 -/-  
brains at P0.   
Figure 2-3:  A schematic summarizing the developmental defects in the anterior 
hypothalamus of Foxd1-/- brains at P0.  Expression of anterior hypothalamic 




Figure 2-4. Posterior and lateral hypothalamic structures are unaffected in Foxd1 -null animals at P0.   
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Figure 2-4:  Posterior and lateral hypothalamic structures are unaffected in 
Foxd1-null animals at P0.  A-L: In situ hybridization on P0 wild-type and Foxd1-/- 
coronal sections.  There was no change in markers of the mammillary body (black 
arrowheads, A, B, K, L).  Arcuate expression of Sst (open arrowheads, E, F), and Th 
(black arrowheads, G, H) was unchanged in Foxd1-/- brains, but Isl1 expression (red 
arrowheads, C, D) was lost.  The DMH was relatively unaffected (black arrowheads, 
E, F, K, L), but as with the arcuate, it too lost expression of Isl1 (open arrowheads, C, 
D).  Isl1 expression in the ventrolateral VMH was also lost in Foxd1-/- brains (yellow 
arrowheads, C, D).  The lateral hypothalamus had normal Trh expression (open 
arrowheads, I-L), but reduced Isl1 expression (black arrowheads, C, D).  Other 
unaffected brain areas were the tuberomammillary terminal (red arrowheads, E, F) and 
the supraoptic nucleus (red arrowheads, I, J). M, N: Schematics showing the overall 
organization of posterior hypothalamic nuclei at two coronal planes.  M corresponds 
to the coronal plane featured in C-H and K, L, and N corresponds to sections A, 




Figure 2-5. Proliferation is not affected by loss of Foxd1. 
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Figure 2-5:  Proliferation is not affected by loss of Foxd1.  A-
B:  Immunohistochemistry staining against EdU (red) and DAPI (blue) on E12.5 wild-
type and Foxd1-/- coronal sections after a 2hr EdU pulse.  Red scroll bars indicate the 
counted portion of the section containing the prethalamus and hypothalamus.  C: 
Quantification of EdU-positive cells relative to area (µm2) in control versus Foxd1-/- 




Figure 2-6. At E12.5, when Foxd1  expression is highest, hypothalamic markers are largely unaffected by 
loss of Foxd1.  
Figure 2-6:  At E12.5, when Foxd1 expression is highest, hypothalamic markers 
are largely unaffected by loss of Foxd1.  A:  Schematic demonstrating the 
organization of the hypothalamus and prethalamus at the coronal level depicted in B-
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O.  B-O:  In situ hybridization on E12.5 wild-type and Foxd1-/- coronal sections. Some 
markers of the ventral AH (open arrowheads, B-E, H-K), and prethalamus (black 
arrowheads, B, C, H-K) were unaffected in Foxd1-/- brains.  However, Vax1 and Six3 
were both down in the ventral AH (open arrowheads, F, G, N, O) and Six3 expression 
in the prethalamus was also reduced (black arrowheads indicate the prethalamus, red 
arrowhead shows missing expression domain, F, G).  Sim1 expression in the 




Figure 2-7. Anterior hypothalamic markers are reduced, but not absent, at E16.5  
Figure 2-7:  Anterior hypothalamic markers are reduced, but not absent, at 
E16.5.  A-H: In situ hybridization on E16.5 wild-type and Foxd1-/- coronal sections.  I: 
A schematic demonstrating the organization of the hypothalamus and prethalamus at 
the coronal plane shown in A-H.  A-F:  Markers of the anterior hypothalamus and 
SCN that are drastically reduced or lost at P0 are only mildly affected at E16.5 (black 
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arrowheads in A and B show the anterior hypothalamus, black arrowheads in C-F 
indicate the SCN).  G, H:  At E16.5, Sst is not yet expressed in the PeVN (black 




Figure 2-8. GO Analysis: Biological Processes. 
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Figure 2-8:  GO Analysis: Biological Processes.  A, B:  Gene ontology analysis of 
biological processes performed on the significantly differentially expressed genes from 





Figure 2-9. GO Analysis: Cellular Compartment. 
Figure 2-9:  GO Analysis: Cellular Compartment. A, B:  Gene ontology analysis 
of cellular compartment localization performed on the significantly differentially 
expressed genes from RNA-Seq analysis of E12.0/E12.5 (A) and E17.5 (B) wild-type 









Figure 2-10:  GO Analysis: Molecular Function.  A, B:  Gene ontology analysis of 
molecular functions performed on the significantly differentially expressed genes from 




Table 2-1. E17.5 RNA-Seq. 
51 
 
Table 2-1:  E17.5 RNA-Seq.  RNA-Seq analysis comparing RNA expression in wild-
type and Foxd1-/- E17.5 hypothalami.  Differentially expressed genes were determined 




Table 2-2. E12.0/E12.5 RNA-Seq. 
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Table 2-2:  E12.0/E12.5 RNA-Seq.  RNA-Seq analysis comparing pooled RNA 
expression in wild-type and Foxd1-/- E12.0 and E12.5 hypothalami.  Differentially 




Table 2-3. E12.0/E12.5 GO analysis summary. 
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Table 2-3:  E12.0/E12.5 GO analysis summary.  A summary of the GO analyses 
and the genes which have been included for each category within biological processes, 
cellular compartments, and molecular function, and the associated p-value, for the 
E12.0/E12.5 RNA-Seq data set.  
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Table 2-4:  E17.5 GO analysis summary for cellular compartments and 
molecular function.  A summary of the GO analyses and the genes which have been 
included for each category within cellular compartments and molecular function, and 
the associated p-value, for the E17.5 RNA-Seq data set.  












Table 2-5:  E17.5 GO analysis summary for biological processes.  A summary of 
the GO analyses and the genes which have been included for each category within 






Nothing is known about the role of the transcription factor Foxd1 in the 
development of the hypothalamus and prethalamus.  Foxd1 is a member of the 
forkhead family of transcription factors, which have a highly conserved binding 
domain sequence, RTAAAYA.  Foxd1 most closely resembles its family member, 
Foxd4; they are nearly identical in their forkhead domain but differ greatly in the 
amino acid sequence bordering the forkhead domain and both are capable of 
bending DNA at least 80-90⁰ upon binding (Pierrou et al., 1994).  Previous research 
has shown through in situ hybridization and fate-mapping experiments that Foxd1 is 
expressed early in the anterior hypothalamus and prethalamus, and is expressed at 
some point in development in every cell of the prethalamus and hypothalamus 
(Shimogori et al., 2010; Salvatierra et al., 2014).  We have confirmed this, and also 
shown that Foxd1 expression is turned on early, at least as early as E8.5, and is 
broadly expressed in the presumptive hypothalamus and prethalamus at this time.  
By E12.5, its expression is restricted to the ventricular zone of the prethalamus and 
anterior hypothalamus.  Despite its early broad expression, loss of Foxd1 appears to 
have a very selective effect on the development of the anterior hypothalamus.  
However, this is consistent with its prolonged expression in this area.   
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 The transcriptional network governing development of the dorsal anterior 
hypothalamus (the PVN and PeVN) has already been somewhat well established.  
Work in zebrafish has shown that Fezf2 and Olig2 are necessary for expression of the 
dorsal anterior hypothalamic markers Otp and Sim1 (Blechman et al., 2007; 
Borodovsky et al., 2009), and are expressed in mouse hypothalamus by E11.5 
(Bedont et al., 2015; Shimogori et al., 2010; http://www.brain-map.org).  Otp, Sim1 
and the Sim1 binding partner Arnt2 are known to be responsible for terminal factor 
and neuropeptide expression in these areas (Bedont et al., 2015, Borodovsky et al., 
2009; Acampora et al., 1999; Goshu et al., 2004; Hosoya et al., 2001; Michaud et al., 
1998; Ryu et al., 2007; Wang and Lufkin, 2000).  Brn2 and Sim2 act downstream of 
Otp and Sim1; Brn2 is necessary for the expression for Avp and Oxt in the PVN and 
the SON, and Crh in the PVN, while Sim2 is necessary for expression of Trh in the 
PVN and PeVN and Sst in the PeVN (Goshu et al., 2004; Nakai et al., 1995; 
Schonemann et al., 1995).  Interestingly, every one of these genes was downregulated 
in Foxd1-/- mice at P0, with the exception of Trh in the PVN and PeVN.  Avp was 
down in the PVN at P0, as determined by in situ hybridization, and it was one of the 
significantly downregulated genes in the RNA-Seq analysis performed at E17.5.   Sst 
was lost from both the PVN and the PeVN, as determined by in situ hybridization at 
P0.  Both Oxt and Crh were also significantly downregulated according to the RNA-
Seq results from E17.5.  These results suggest that Foxd1 acts upstream of 
Fezf2/Olig2/Otp/Sim1 to specify anterior hypothalamic fate, although there must 
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some sort of compensatory mechanism that is able to drive Trh expression in the 
PVN in the absence of Foxd1.  Sim1 expression was unaltered in Foxd1-/- mice at 
E12.5, but it may show altered expression at later time points.  Further work will be 
needed to determine if expression of Fezf2, Olig2, Otp, Sim1, Brn2, and Sim2 are 
disrupted in the dorsal anterior hypothalamus of Foxd1-/- mice at other time points, 
as we hypothesize.   
 Much less is known about the molecular determinants of SCN development 
(Abrahamson and Moore, 2001).  Four transcription factors have been shown to be 
essential for SCN formation in the hypothalamus: Six3, Six6, Lhx2, and Rax (Clark 
et al., 2013; Roy et al., 2013; VanDunk et al., 2011; Orquera et al., 2016).  In the 
studies of Lhx2 and Rax, the latest time point examined was E12.5, so in neither case 
was the development of the mature markers of the SCN truly examined.  Rather, 
both saw a loss of ventral anterior hypothalamic markers after deletion of either 
Lhx2 or Rax.  In Lhx2 KO mice, there was a reduction of Lhx1 in the ID and a 
complete loss of Lhx1 in the most ventral portion of its expression domain, from 
which the SCN develops.  In addition, Arx and Vax1 were both significantly down 
in Lhx2-/- embryos (Roy et al., 2013). In contrast, in Foxd1-/- mice, only Vax1 was 
down at E12.5, and not as significantly as in Lhx2-/- mice.      
Rax expression is detected in the presumptive hypothalamus as early as E7.5.  
When it is deleted at around E8.0 to E8.5, there is a reduction in markers of mature 
postmitotic neurons in the anterior hypothalamus including Th, Sst, Otp and Lhx1 at 
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E12.5 (Orquera et al., 2016).  Although Foxd1 and Rax are both expressed in early 
hypothalamic progenitors, and appear to be required for anterior hypothalamic 
specification, they are not redundant factors; Rax is required for early expression of 
anterior hypothalamic markers, while Foxd1 appears to be required for their 
maintenance, since there was only a mild phenotype at E12.5 in the Foxd1 null 
mutants.  Rax and Foxd1 null mutants are also not identical at P0; Rax deletion 
reduces Th expression in the anterior hypothalamus, while Foxd1 deletion does not, 
despite the fact that Th does have a Foxd1 binding domain in its promoter, at least in 
humans (Zhang et al., 2010). 
Six3 is expressed as early as E10.5 in the ventral hypothalamus, and overlaps 
Rax expression (VanDunk et al., 2011; Oliver et al., 1995).  By E11.5, Six6 is 
expressed in an overlapping domain in the anteroventral hypothalamus with Six3.  
Conditional knock-out of Six3 from the hypothalamus resulted in a complete loss of 
Rora and Avp from the ventral anterior hypothalamus at E18.5 (VanDunk et al., 
2011).  In addition, there was no cell clustering in the SCN or other histological 
evidence for nucleogenesis, which is also the case in Foxd1-/- mice.  It also appeared 
as though Avp was partially reduced in the PVN as well in these mutants, although 
the authors of the original paper claim that defects were restricted to the SCN.  At 
E15.5, Six3 deletion also resulted in a loss of Lhx1 and Rora from the SCN.    
Lhx1 is the first marker expressed in mature, postmitotic SCN neurons, but 
loss of Lhx1 results in a milder phenotype than loss of Foxd1 (Bedont et al., 2015; 
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Bedont et al., 2014).  Lhx1 appears to be responsible for terminal differentiation of 
the SCN, and expression of its neuropeptides, but conditional Lhx1 mutants still 
have a SCN, as shown by expression of markers like Vipr2 and Gad67, as well as 
DAPI staining showing cell aggregation and nucleogenesis (Bedont et al., 2014).  
This suggests that Foxd1 is acting upstream of Lhx1, as Foxd1-/- mice show a much 
more severe SCN defect.   
 When considered in the context of our current understanding of SCN and 
anterior hypothalamic development, our results from the analysis of Foxd1-/- mice 
suggest a model in which Foxd1 is necessary to maintain expression of Six3 and 
Vax1, and the loss of anterior hypothalamic markers is then primarily a result of 
reduced Six3 and Vax1 expression.  Both Six3 and Vax1 expression were reduced at 
E12.5.  Both of these genes were also pulled out of the RNA-Seq analysis as 
significantly downregulated genes in the Foxd1-/- mice hypothalamus; Six3 was 
significantly down at E12.5 and Vax1 was significantly down at E17.5.  Six3-/- mice 
show similar developmental deficits as Foxd1-/- mice at E18.5/P0, including a loss of 
any discernible anatomical SCN, as well as a complete absence of any Lhx1 
expression.  While Rora and Avp were completely absent in the Six3-/- mutant, these 
markers were significantly down but not gone in Foxd1-/- mice.  This is likely a 
reflection of the fact that Six3 expression was not completely lost in Foxd1-/- mice at 
E12.5.   
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It is not known what effect loss of Six3 has on more dorsal anterior 
hypothalamic structures.  There may have been an effect on Avp expression in the 
PVN in the Six3-/- mice, but there was no examination of PeVN markers or other 
PVN markers (VanDunk et al., 2011).  A closer examination of Six3-/- mice would 
determine if Six3 is also necessary for dorsal anterior hypothalamic structures, 
perhaps upstream of Otp/Sim1.   
Although Six3 and Vax1 expression were both reduced at E12.5, there was 
no defect observed in postmitotic markers of the anterior hypothalamus until E16.5.  
It is unclear if this is due to a delayed need for Six3 and Vax1 in maintaining 
expression of these genes, or if expression of Six3 and Vax1 was lost completely at 
later stages of development in Foxd1-/- mice.  To test this, Six3 and Vax1 expression 
must be examined at later time points in the Foxd1-/- mutants, however the RNA-Seq 
results suggest that Vax1 expression stayed down until P0.    
While Rax is necessary for expression of Lhx1 and Sst at E12.5, Foxd1 is not; 
this suggests that that although Rax and Foxd1 are expressed around the same time, 
Rax is necessary to drive their expression early in development, while Foxd1 is 
necessary to maintain their expression through regulation of Six3 and Vax1.  Foxd1 
and Lhx2 may show partial redundancy in the regulation of Vax1, and potentially 
Six3 as well (since the role of Lhx2 in control of Six3 expression is unknown).  Both 
Foxd1 and Lhx2 null mutants show reduced Vax1 expression, but Vax1 was 
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preserved in the more dorsal part of its domain in the Lhx2 null mutant, and in the 
more ventral portion in Foxd1-/- mice.   
Foxd1 does not appear to be essential for survival of cells in the anterior 
hypothalamus, nor does it regulate proliferation.  In contrast, Lhx1 conditional 
knock-out mice have increased cell death in the SCN by P0, which accounts for the 
reduced size of the SCN (Bedont et al., 2014).  There was no increase in cell death in 
Foxd1-/- mice, despite the lack of Lhx1 at P0, which is likely due to the fact that Lhx1 
is expressed at normal levels at E12.5, and does not show reduced expression until 
E16.5.  Thus, the lack of a discernible SCN at P0 is most likely due to a failure of 
cellular aggregation in this area.        
  It is unclear why loss of Foxd1 has no effect on the development of the 
prethalamus.  Foxd1 expression persists longest in progenitors in this brain region, 
and Six3 expression is reduced in the prethalamus at E12.5 in Foxd1-/- mice.  .  
However, we only examined a limited number of prethalamic markers and it is 
possible that loss of Foxd1 has a subtle effect on prethalamic development which we 
have yet to discover.  Alternatively, Six3 may not be necessary for prethalamic 
development, due to compensation by other transcription factors in this area.   
 Further work must be done to better understand the role of Foxd1 in 
anterior hypothalamic development. Targeted overexpression of Six3 or Vax1 using 
in utero electroporation in Foxd1-/- embryos could determine if Foxd1 is acting solely 
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through regulation of these transcription factors, or if it is mediating anterior 
hypothalamic development through other means.  There still remains the question of 
why the loss of Foxd1 has a selective effect on the development of the anterior 
hypothalamus, despite being expressed throughout the hypothalamus and 
prethalamus.  Other forkhead transcription factors may be able to partially 
compensate for the loss of Foxd1, such as Foxm1, which is broadly expressed 
throughout the hypothalamus at E11.5 and E13.5 (http://www.brain-map.org).  




2-11. Schematic demonstrating our model of the role of Foxd1 in anterior hypothalamic development.  
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Figure 2-11:  Schematic demonstrating our model of the role of Foxd1 in 
anterior hypothalamic development.  A:  The known transcriptional regulatory 
pathways governing development of the dorsal anterior hypothalamus.  We 
hypothesize that Foxd1 regulates Six3 and Vax1, which in turn may regulate Fezf2 
and Olig2.  B:  The transcription factors known to be involved in development of the 
SCN.  We hypothesize that Foxd1 is controlling SCN development through 
regulation of Six3 and Vax1.  In both the dorsal anterior hypothalamus and the 
SCN, we hypothesize that Foxd1 is working in conjunction with other, unknown 
transcription factors, due to the incomplete loss of Six3 and Vax1  in the Foxd1-null 




2.3 METHODS AND MATERIALS 
 
2.3.1 Embryo Collection 
 
Matings were set up in the evenings and the presence of a plug the next morning 
indicated embryonic day 0.5 (E0.5).  Embryos were harvested at embryonic day 12.5 
(E12.5), E16.5, E17.5, E18.5 and P0.  Foxd1-Cre+/- animals (Humphreys et al., 2008) 
were mated to each other to generated Foxd1-Cre+/+ (Foxd1-/-) embryos/pups.     
 
2.3.2 High-Quality Chromogenic In situ Hybridization 
 
Pregnant dams were sacrificed via cervical dislocation and the embryos were harvested 
into ice-cold 1xPBS (phosphate buffered saline) treated with DEPC.  Embryos were 
dissected (tail samples were kept for genotyping) and their whole heads fixed in 4% 
PFA (paraformaldehyde) in 1xPBS-DEPC while rotating at 4⁰C.  Following fixation, 
embryos were washed 2x5 min in 1x-PBS-DEPC then sucrose sunk in 30% sucrose in 
1xPBS-DEPC at 4⁰C for a minimum of one day.  Embryos were then embedded in 
gelatin (10% gelatin with 30% sucrose in 1xPBS-DEPC).  Following hardening of the 
gelatin, the blocks were cut and stored in 4% PFA; 30% sucrose in 1xPBS-DEPC for 
a minimum of one week at 4⁰C to allow the blocks to sufficiently fix before sectioning.   
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All steps after this point were done under RNAse-free conditions.  The gelatin blocks 
were sectioned on a freezing microtome at 40µm thickness.  Sections were collected 
in 1xPBS-DEPC and stored at 4⁰C until mounting (stored for a maximum of 4 hours).  
Sections were mounted in 0.5x PB-DEPC (phosphate buffer) onto Superfrost Plus 
slides (Fisher Scientific) and allowed to dry vertically for a minimum of overnight to a 
maximum of two days.   Following drying, sections were immediately put through the 
first day of the high-quality in situ hybridization protocol.  All washes were performed 
in 5-slide mailers that had been treated with 0.3M NaOH.  Briefly, slides were fixed in 
4% PFA in 1xPBS-DEPC for 15 minutes followed by 3x5 minute washes in 1xPBS-
DEPC (all done at room temperature).  Slides were then digested in a proteinase K 
solution (1µg/ml in 100mM Tris-HCl pH 8.0 and 50mM EDTA pH 8.0) at 37⁰C for 
30 minutes, followed by another fixation with 4% PFA in 1xPBS-DEPC for 15 
minutes at room temperature.  Slides were then washed in 1xPBS-DEPC (3x5 min).  
At this point, slides were either placed in hybridization buffer and stored at -20⁰C or 
immediately placed in hybridization buffer with probe and hybridized.  For each new 
probe, 70µl probe was added to 1mL of hybridization buffer and heated at 80⁰C in 
order to denature them, then immediately placed on ice before adding to the mailer 
for a total volume of 14mL hybridization buffer (including probe).  Mailers with fewer 
than 5 slides were given RNAse-free blank slides.  Used probe/hybridization solution 
was stored at -20⁰C and used multiple times, refreshing with 15µl probe when needed.  
Slides were hybridized at 70⁰C overnight in a hybridization oven.  After hybridization, 
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RNAse-free conditions were no longer necessary.  Slides were incubated in Solution 
X (50% formamide in 2x SSC and 1% SDS) 3x45 min at 70⁰C.  Slides were then 
washed 3x15 min in 1xTBST (25.0 mM Tris-HCl pH7.5, .136 M NaCl, 2.68 mM KCl, 
1% Tween-20) at room temperature then blocked in 10% lamb serum in 1xTBST at 
room temperature for 1 hr.  Slides were then incubated in preabsorbed primary 
antibody (1:5000 anti-DIG a.p. fab fragments; protocol below) in 1% lamb serum and 
1xTBST, overnight at 4⁰C.  Following antibody incubation, the slides were washed in 
1xTBST 3x15 min, then 1x10 min in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 
9.5, 50 mM MgCl2, 1% Tween-20, 2mM levamisole).  The slides were then developed 
in the color reaction step in NTMT containing the chromogens 5-bromo, 4-chloro, 3-
indolylphosphate (BCIP) and nitroblue tetrazolium (NBT), at either room temperature 
or 4⁰C.  The color reaction was stopped in TE stop buffer (10 mM Tris-HCl pH 7.5, 
50 mM EDTA pH 8.0) for a minimum of 1 hr, followed by DAPI staining for 5 min 
(1:5000 in 1xPBS) then a 1xPBS wash for 5 min.  Slides were coverslipped with gelvatol 
and allowed to dry overnight before imaging.   
 
2.3.3 Preabsorbed Antibody 
 
Age appropriate embryo powder was rehydrated in 1xTBST at 70⁰C for 30 min, 
rotating.  It was cooled on ice for 10 minutes, then the primary antibody was added as 
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well as 1% lamb serum.  It was then incubated at 4⁰C for one hour, rotating.  After 
allowing the solution and embryo powder to settle, the supernatant containing the 
antibody was taken and added to a solution of 1xTBST and 1% lamb serum. 
 
2.3.4 Fresh-Frozen Chromogenic In situ Hybridization 
 
Embryos were harvested fresh frozen and immediately embedded in OCT (Tissue-
tek) and frozen on dry ice.  Blocks were sectioned on the cryostat at 20µm thickness 
and immediately dry mounted onto Superfrost Plus slides.  Slides were allowed to dry 
and then were stored at -80⁰C.  When ready to be used, the slides were allowed to 
thaw at room temperature a minimum of 30 min before beginning the protocol.  The 
first day of the in situ hybridization was done under RNAse-free conditions, and all 
slide boxes and slide holders were soaked in 0.3M NaOH before use.  All incubations 
were done at room temperature unless otherwise noted.  Slides were fixed in 4% PFA 
in 1xPBS-DEPC for 10 min, then washed 3x 5 min in 1xPBS-DEPC.  Slides were then 
incubated in acetic anhydride (.0027% in .1M TEA pH 8.0) for 10 min followed by 
another wash in 1xPBS-DEPC, 3x 5 min.  Slides were then incubated in hybridization 
buffer for 2 hours prior to adding probe in hybridization buffer and coverslipping with 
siliconized coverslips.  Slides were hybridized at 68⁰C overnight.  Probes were 
denatured at 80⁰C for 5 minutes prior to hybridization.  Hybridized slides were washed 
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in 5x SSC at 65⁰C for approximately 45 min until the coverslips could be removed 
easily.  Then the slides were washed in 0.2x SSC, 2x 45 min at 65⁰C, followed by 1x 5 
min at room temperature.  Slides were then washed 1x 5 min in B1 buffer (.2M Tris-
HCl pH 7.5, .3M NaCl) then blocked in 5% heat-inactivated sheep serum in B1 for 1 
hour.  Slides were incubated in primary antibody (1:5000 anti-DIG a.p. in 5% heat-
inactivated in B1) overnight at 4⁰C.  Prior to developing, the slides were washed in B1 
3x 5 min then 1x 5 min in B3 solution (.1 M Tris-HCl pH 9.5, .05 M MgCl2, .1 M 
NaCl).  The color reaction proceeded in B3 with BCIP and NBT with .24mg/mL 
levamisole) under dark conditions at either room temperature or 4⁰C.  The color 
reaction was extinguished in TE stop buffer (10 mM Tris-HCl pH 7.5, 50 mM EDTA 
pH 8.0).  Slides were DAPI stained in 1:5000 DAPI in 1xPBS for 5 min, followed by 
a 1xPBS wash for 5 min before coverslipping with gelvatol.  Slides were allowed to dry 




Probes were generated using the following sequences as templates: 
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2.3.6 EdU Staining and Cell Counting 
 
Pregnant dams were injected with 50 mg/kg Edu (20 mg/mL in saline) on embryonic 
day E12.5 and then sacrificed via cervical dislocation 2 hours later.  The embryos were 
harvested in ice cold 1xPBS and the whole heads fixed in 4% PFA in 1xPBS at 4⁰C 
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overnight, rotating.  The embryos were then washed 2x5 min in 1xPBS at 4⁰C then 
sucrose sunk in 30% sucrose in 1xPBS and stored at 4⁰C for a minimum of one 
day.  Following cryoprotection, the embryos were embedded in OCT blocks on dry 
ice, then sectioned on a cryostat at 25µm thickness.  Sections were immediately dry 
mounted onto Superfrost Plus slides and allowed to dry before storing at -20⁰C.  EdU 
staining was performed using the Click-iT EdU imaging kit from Invitrogen, then the 
slides were coverslipped using Vectashield.  Stained slides were imaged at 40x on a 
Keyence microscope.  Between 5 and 6 sections per animal were counted using 
ImageJ.  All counting was done manually and blinded.  The number of EdU-positive 
cells was taken as a fraction of the total area of the hypothalamus measured in 
µm2.  The values of the sections were averaged for each individual, and then compared 
using a 2-tailed t-test.  Two animals per genotype were used. 
 
 
2.3.7 TUNEL Staining 
 
 E12.5 embryos were harvested and post-fixed in 4% paraformaldehyde for a 
minimum of overnight at 4⁰C.  Slides were sucrose sunk in 30% sucrose in 1xPBS 
after 3x5 min 1xPBS washes.  Following sucrose sinking, the embryos were embedded 
in OCT blocks on dry ice, and sectioned on a cryostat at 25μm thickness.  Sections 
were immediately dry mounted onto Superfrost Plus slides and allowed to dry before 
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storing at -20⁰C.  Slides were allowed to thaw to room temperature until beginning the 
protocol.  TUNEL staining was performed according to the protocol for 
cryopreserved tissue in the In Situ Cell Death Detection Kit-TMR red (Roche).  A 
positive control was used (3000 U/mL DNAse I).  Slides were DAPI stained then 
coverslipped using Vectashield, then imaged at 20x and 40x in the red channel on a 




Hypothalami were dissected at E12.5 and stored at -80⁰C.  After genotyping, the RNA 
was extracted using the RNeasy kit from Qiagen.  The RNA from each genotype were 
pooled and then sent for quality control analysis to determine concentration and purity 
via Nanodrop and electrophoresis.  The E12.5 RNA had significant gDNA 
contamination, so DNAse digestion using the Qiagen kit was performed and then the 
RNA was resent for quality control before RNA-sequencing.  A cDNA library was 
generated and barcoded for each pooled RNA sample, than sequenced to a paired-end 
read depth of 100 cycles using Illumina HiSeq 2500.  The raw RNA-Seq results were 
mapped onto mm9 genome (NCBI37) using the default parameters in Tophat and 
Cufflinks (Trapnell et al, 2012) to generate gene expression FPKM (fragments per 
kilobase of exon per million).  Cuffdiff was used to determine differentially expressed 
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genes between the control and mutant samples.  Differentially expressed genes with a 




 Embryos were harvested and post-fixed in 4% paraformaldehyde for a minimum of 
overnight at 4⁰C.  Slides were sucrose sunk in 30% sucrose in 1xPBS after 3x5 min 
1xPBS washes.  Following sucrose sinking, the embryos were embedded in OCT 
blocks on dry ice, and sectioned on a cryostat at 25μm thickness.  Sections were 
immediately dry mounted onto Superfrost Plus slides and allowed to dry before storing 
at -20⁰C.  Before beginning immunohistochemistry, the slides were allowed to dry at 
room temperature, and then marked with a pap pen to isolate the sections.  Slides were 
incubated in blocking buffer (10% HIHS in 0.1% TX-100 in 1xPBS) for at least two 
hours at room temperature, before incubating in primary antibody overnight at 
4⁰C.  Antibodies used were as follows:  rabbit anti-GFP 1:1000 (Life Technologies 
A6455 polyclonal) and rat anti-dsRed 1:1000 (Chromotek 5F8 monoclonal).  Slides 
were washed 3x5 min in 1xPBS-T then incubated in secondary antibody in blocking 
buffer for two hours at room temperature.  Secondary antibodies used were goat anti-
rabbit-488 and donkey anti-rat-555.  The slides were then washed 5 min in 1xPBS-T 
before DAPI staining in 1:5000 DAPII in 1xPBS-T for 5 min.  Slides were then rinsed 
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3x5 min in 1x-PBS-T before coverslipping in Vectashield.  Stained slides were imaged 
















One of the many unanswered questions concerning hypothalamic development is the 
mechanism of patterning: how is the hypothalamus patterned such that anatomically 
and functionally diverse nuclei are specified in the correct location and relation to each 
other (Blackshaw et al., 2010)?  The hypothalamus is unique in the brain for the 
complexity of its anatomy, which has complicated research into its development.  One 
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way to better understand hypothalamic development has been to arrange it within a 
conceptual anatomical framework within the larger context of the forebrain, called the 
prosomere model.  The prosomere model of forebrain development was originally 
proposed by John Rubenstein and Puelles in 1993, and held that the embryonic 
forebrain is composed of segmented domain structures known as “prosomeres,” 
analogous to the rhombomeres of the hindbrain.  Originally the theory held that there 
were 6 prosomeres (p1-p6), which were divided into the diencephalon (p1-p3), 
including the thalamus and prethalamus, and the secondary prosencephalon (p4-p6) 
including the hypothalamus and telencephalon (Rubenstein et al., 1994).  In 2003, 
Rubenstein and Puelles updated the model due to new gene expression data (Puelles 
et al., 2000; Bulfone et al., 1995), Rohr et al., 2001).  The p4-p6 prosomeres were 
condensed into the secondary prosencephalon which they divided into the 
telencephalon and the rostral diencephalon (hypothalamus) (Puelles and Rubenstein, 
2003).  The model maintained that these separate domains (p1-p3 and the secondary 
prosencephalon) and their corresponding unique gene expression patterns, are 
indicative of separate patterning mechanisms.  Most importantly, it suggested that the 
hypothalamus and the prethalamus (located in p3) are patterned independently of each 
other2.  
                                                          
2 Since beginning this research, the prosomere model has been updated yet again, this time dividing 
the secondary prosencephalon into two hypothalamo-telencephalic prosomeres (hp1 and hp2) 
(Ferran et al., 2015).  They argue that one would “expect[s] some differential molecular pattern 
across adjacent neuromeres that share other determinants…In that case, the crucial expected 
observation is that various partial zonal or microzonal patterns restricted to each of the units show 
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 Gene expression data from a large screen (Shimogori et al., 2010), suggests 
that the prosomere model is inaccurate as regards the separation of the hypothalamus 
and prethalamus.  Several genes (Foxd1, Isl1, Emx2, Zfp312, Pitx2 and Gdf10) have 
expression patterns composed of stripes which transverse both the hypothalamus and 
prethalamus.  Such contiguous gene expression patterns should not exist according to 
the prosomere model, and may have been missed due to the late timepoint (E15.5) 
used when developing the prosomere model.  These stripes comprise parallel domains 
across the AP axis.  These data suggest that the prethalamus and hypothalamus are 
more linked developmentally than suggested by the prosomere model and may be 
patterned together.   
 Little is known about how the hypothalamus and prethalamus develop and so 
to determine if they are patterned together, it was necessary to uncover a common 
patterning mechanism.    Elsewhere in the nervous system, development is governed 
by a combination of intrinsic factors (such as transcription (Virolainen et al., 2012) and 
competency factors) and extrinsic factors (such as morphogens (Alvarez-Bolado et al., 
2012)).  Cells must then integrate this information in a probabilistic, rather than 
                                                          
a common transverse boundary that agrees with the postulated interneuromeric border.”  In other 
words, stripe gene expression patterns, such as those shown in Shimogori et al., 2010, can be ignored 
as long as smaller domains within the postulated prosomeric boundaries conform to their 
preconceived determination of their boundaries, i.e. their model is based on gene expression patterns 
until it is not.  However by ignoring gene expression domains that run counter to the basic tenets of 
the prosomere model, one runs the risk of missing the clues such expression patterns suggest about 
potential patterning mechanisms which may exist that violate their model, such as the one discussed 
in this thesis.  
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deterministic, fashion, within the context of a larger overall selective process to 
maintain the correct population size of a particular cell type (Descalzo and Arias, 
2012).   
 Morphogens are especially important in areas of high neuronal subtype 
diversity.  They are often secreted from a single source (often an organizer) which 
establishes a concentration gradient so that progenitors at increasing distance from the 
source receive proportionally less morphogen signal.  For example, in the spinal cord, 
Wnt and Shh are secreted in an opposing concentration gradient from the roof plate 
and floor plate, respectively (Yu et al., 2008; Alvarez-Medina et al., 2008).  These two 
molecules together pattern the spinal cord and specify different neuronal subtypes 
found along the dorso-ventral axis, although Bmp plays a much more important role 
than Wnt in dorsal patterning.   
 There is evidence to suggest that Wnts may be similarly involved in 
hypothalamic and prethalamic development.  There are two primary classes of Wnt 
signaling pathways: β-catenin dependent (canonical) and β-catenin-independent (non-
canonical) signaling (Valenta et al., 2012).  In the canonical signaling pathways, under 
basal conditions, cytosolic β-catenin (i.e. not actively involved in adherens junctions) 
is targeted for degradation by a destruction complex (Hagemann et al., 2015).  Upon 
Wnt binding to its Frizzled receptor, it triggers the inhibition of the destruction 
complex, thereby allowing cytosolic β-catenin to accumulate in the cell and enter the 
nucleus where it activates (or in some cases, represses) target genes through its 
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interactions with the Tcf/Lef family of transcription factors (Freese et al., 2010, Logan 
and Nusse, 2004, Hagemann et al., 2015).  Canonical Wnt signaling has been 
implicated in Wnt-mediated patterning elsewhere in the central nervous system, where 
it often serves as a posteriorizing factor (Gulacsi and Anderson, 2008; Bluske et al., 
2012; Kapsimali et al., 2004), and we suspected its involvement in the hypothalamus 
and prethalamus as well.  Our goal, therefore, was two-fold: to demonstrate the role 
of canonical Wnt signaling in patterning of the hypothalamus and prethalamus, and by 
so doing, determine whether these two structures are patterned together as a single 
developmental unit.  
 
3.1.2 Loss of Canonical Wnt Signaling Results in an Anteriorized 
Hypothalamus and Displaced Pituitary 
 
There are two main sources of Wnt within the developing hypothalamus, as well as a 
third source of Wnt within the zona limitans intrathalamica (ZLI) (an organizer 
adjacent to the developing prethalamus): Wnt8b in the mammillary, which forms a 
contiguous stripe with Wnt3/3a in the prethalamus, and Wnt7a/b in the prethalamus 
and anterodorsal hypothalamus (Clements et al., 2009) (Figure 1 A, B).   They are 
expressed at different times and most likely serve different developmental 
functions.  Wnt 3/3a and Wnt8b are first expressed at embryonic day 8.5 (E8.5), well 
before hypothalamic neurogenesis begins (Byerly and Blackshaw, 2009) (Figure 1A), 
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suggesting that it may regulate spatial identity within the developing 
hypothalamus.  This is supported by studies in zebrafish showing that Wnt8b and Lef1 
are important for neurogenesis (Wang et al., 2009; Lee et al., 2006) and differentiation 
in the posterior hypothalamus (Wang et al., 2012).  We therefore hypothesized that a 
Wnt8b concentration gradient established from the posterior mammillary region 
patterns the murine hypothalamus through β-catenin-dependent signaling.  In addition 
to this posterior-restricted expression of Wnt8b prior to neurogenesis, we observed 
Wnt7a/b expression in hypothalamic and prethalamic interneuron progenitors, 
coincident with the onset of neurogenesis (~E10.5, Figure 1B).  The role of Wnt7a/b 
in interneuronal development is unclear.  Given the many developmental functions of 
Wnts, it may have a role in progenitor proliferation or neuronal subtype specification 
and differentiation. 
To address the role of canonical Wnt signaling in patterning of the 
hypothalamus alone, we utilized a Cre line driven by the Nkx2.1 gene 
promoter.  Nkx2.1 is one of the earliest markers of the presumptive hypothalamus 
and is turned on early in development, approximately E9.0-9.5.  It is expressed along 
the ventral surface of the anterior-posterior (AP) axis but is excluded from more dorsal 
structures.  Crucially, it is not expressed in the prethalamus (Figure 1C).  By crossing 
Nkx2.1-Cre+/-; β-cateninf/+ mice to floxed β-catenin-expressing mice, we were able to 
selectively delete β-catenin from early hypothalamic progenitors.  
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        If canonical Wnt signaling was functioning to posteriorize the hypothalamus, 
then by removing β-catenin we would expect to see an anteriorization phenotype; an 
expansion of anterior structures at the expense of posterior structures, and 
concomitant loss of markers of posterior structures.  This is indeed what we 
saw.  Markers of the supramammillary nucleus, including Foxa1 (Figure 2 A, B) and 
Irx5 (Figure 2 C, D) were significantly reduced.  The mammillary was similarly 
affected, with Foxb1 (Figure 2 E, F), Sim1 (black arrowheads, Figure 2 G, H; Figure 4 
A-J) and Zfp312 (data not shown) all significantly down.  The gene Lef1, in addition to 
being a marker of the premammillary nucleus (PMN), is also one of the early effector 
genes of canonical Wnt signaling and so was an effective readout of the level of 
reduction achieved in our loss-of-function (LOF) mutants.  It was significantly 
reduced in the premammillary (Figure 2 I, J), although not eliminated, suggesting that 
we did not achieve a complete ablation of canonical Wnt signaling, but further 
confirming the posterior phenotype.  Sim1 expression in the paraventricular nucleus 
(PVN) was unaffected (open arrowheads, Figure 2 G, H; Figure 4 A-J), however, likely 
because Nkx2.1 is not expressed in this area and thus the Nkx2.1-Cre is not active 
here.  Conversely, anterior structures appeared to have expanded posteriorly, filling 
the void left by the loss of the posterior structures.  Both Pomc (a marker of the arcuate 
nucleus; Figure 2 Q, R; Figure 3 I-R) and Nr5a1 (a marker of the ventromedial 
hypothalamus (VMH); Figure 2 S, T; Figure 3 S-B’) were expanded into the posterior 
hypothalamus.        
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Canonical Wnt signaling plays an important role in proliferation in the 
hypothalamus, so it was unsurprising that there appeared to be a significant thinning 
of the ventral surface of the hypothalamus in the LOF mutants.  This can be seen 
most dramatically with Arx (Figure 2 O and P), which is normally expressed as a stripe 
through the more dorsal part of the hypothalamus, but in the LOF mutants was 
directly abutting the ventral surface.  A similar phenotype can be seen with Isl1 (Figure 
2 M and N), which is normally expressed in a stripe from the prethalamus through the 
hypothalamus, excluding the posterior hypothalamus, but which occupies the ventral 
portion of the posterior hypothalamus in the LOF mutant.  Another affected marker 
was Lhx6, which is normally expressed in the tuberomammillary terminal (TT) and the 
intrahypothalamic diagonal (ID).  In the LOF mutants, the long TT was significantly 
reduced (open arrowheads, Figure 2 K, L; Figure 3 A-H) and the ID, which is normally 
a more dorsal structure, is positioned close to the ventral surface of the hypothalamus 
(black arrowheads, Figure 2 K, L; Figure 3 A-H).  Nkx2.1 itself was also affected; 
although its expression pattern was not grossly altered, there was a clear reduction in 
the thickness of its expression area, corresponding to the thinned ventral portion of 
the hypothalamus (Figure 4 K-U).  
An unexpected phenotype we observed was a misplacement of the pituitary 
gland.  Normally, the pituitary gland is formed from two structures: Rathke’s pouch, 
which forms the anterior pituitary, originates off of the roof of the oral ectoderm and 
migrates to meet the posterior pituitary, and the posterior pituitary which forms from 
88 
 
a bud off of the ventral hypothalamus itself.  The intermediate lobe then forms from 
the posterior portion of the anterior pituitary (Davis and Camper, 2007; Gaston-
Massuet et al., 2016).  The ventral hypothalamus secretes factors such as Fgf8 which 
are crucial for this process to occur.  In the LOF mutants, the pituitary was displaced 
and invading the hypothalamus proper, forming a wedge within it that can be seen 
most clearly in the sections stained for Nr5a1 (open arrowheads, Figure 3 S-B’) and 
Nkx2.1 (open arrowheads, Figure 4 K-U).  This phenotype was likely a byproduct of 
the disruption of the hypothalamus and altered levels of signaling molecules to the 
pituitary.  
The use of the Nkx2.1-Cre, while informative for investigating the role of 
canonical Wnt signaling within the hypothalamus proper, did not allow us to address 
the possibility of coupled patterning between the prethalamus and hypothalamus.  We 
therefore utilized a different Cre-line driven by a gene which is expressed throughout 
the whole of the prethalamus and hypothalamus during development, Foxd1 (Figure 
1D), and again crossed it to a floxed β-catenin line to generate Foxd1-Cre;Ctnnb1lox/lox 
mice, in which β-catenin is selectively deleted from neural progenitors within the 
hypothalamus and prethalamus starting at approximately E8.5. 
The phenotype observed for the LOF mutants using the Foxd1-Cre was in most 
respects similar to that achieved with the Nkx2.1-Cre; notably, a reduction in posterior 
structures, and an expansion of anterior ones (these results are summarized in Figure 
15).  Lef1 in the premammillary was reduced but not absent (and less so than in the 
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Nkx2.1-Cre driven LOF), indicating again that β-catenin was not completely excised in 
Foxd1-Cre;Ctnnb1lox/lox mutants.  However, the consistent anteriorization phenotype 
seen suggests that even a modest reduction in canonical Wnt signaling can affect 
hypothalamic patterning.  Pitx2 (open arrowheads, Figure 5 M, N), Shh (open 
arrowheads, Figure 5 S, T) and Otp (open arrowheads, Figure 5 K, L) in the 
supramammillary and mammillary were significantly reduced in the LOF mutant, as 
was Sim1 in the mammillary (red arrowheads, Figure 5 Q, R).   Surprisingly, we saw no 
phenotype in more dorsal structures such as the PVN, even though Foxd1-Cre is 
expressed there (unlike the Nkx2.1-Cre) and although there is a small, local source of 
Wnt8b (open arrowhead, Figure 10 S) and corresponding Lef1 expression in the 
anterior hypothalamus (yellow arrowhead, Figure 9 I).  This can be seen with Otp 
(black arrowheads, Figure 5 K, L) and Sim1 (black arrowheads, Figure 5 Q, R).  There 
was also no phenotype within the prethalamus, which is shown by Arx (black 
arrowheads, Figure 5 A, B), and Isl1 (black arrowheads, Figure 5 C, D), despite strong 
expression of the Cre there and its close proximity to the source of Wnt8b in the 
mammillary area of the hypothalamus.  
We observed in this mutant model a similar thinning of the ventral surface of 
the hypothalamus as was seen in Nkx2.1-Cre;Ctnnb1lox/lox mice.  This can be most clearly 
appreciated with Arx (Figure 5 A, B; Figure 6 A-F)) and Isl1 (Figure 5 C, D; Figure 6 
G-L)) in which the hypothalamic expression domains were significantly thinned and 
closer to the ventral surface of the hypothalamus than in the control condition.  A 
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similar defect was seen with Lhx6, which is expressed in the ID and TT (Figure 5 G, 
H).  As in Nkx2.1-Cre; Ctnnb1lox/lox mice, in these mutants, the TT was completely 
absent (black arrowhead, Figure 5 G, H) and the ID (open arrowhead, Figure 5 G, H) 
was positioned more ventrally than in controls.   Similarly, Lhx9, which is normally 
expressed in a dorsal stripe parallel to the AP axis of the ventral surface of the 
hypothalamus, was instead positioned perpendicular to, and in near contact with, the 
ventral surface (black arrowheads, Figure 5 I, J, Figure 6 M-R).     
Given the well-documented role of canonical Wnt signaling in proliferation 
during development, we hypothesized that the thinned hypothalamic neuroepithelium 
was a result of reduced proliferation.  To test this, we injected pregnant dams with 
EdU on day E12.5, and sacrificed them two hours later.  We stained for EdU and 
counted all EdU positive cells relative to total area within the hypothalamus and 
prethalamus.  However, we saw no significant difference in EdU-positive cells 
between control and LOF animals (Figure 7).  We also performed TUNEL staining 
on E12.5 tissue and saw no increase in apoptosis at this time in the LOF mutants (data 
not shown), although there was very little cell death observed in the control tissue 
(approximately 1-2 TUNEL-positive cells per section).  It is possible that we may have 
captured a difference had we looked at proliferation and cell death earlier in 
development (neurogenesis begins at approximately E10.5 in mouse hypothalamus). 
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3.1.3 Constitutively Active Canonical Wnt Signaling Results in Disrupted 
Patterning of the Hypothalamus Pituitary and Prethalamus 
 
If loss (or knockdown) of canonical Wnt signaling leads to a reduction in posterior 
structures and a corresponding expansion of anterior structures, then we would expect 
that enhanced canonical Wnt signaling should have the opposite effect on 
hypothalamic development.  To test this, we generated a constitutively active form of 
β-catenin by deleting the inhibitory domain of the gene.  We achieved this using a line 
in which the third exon (containing the phosphorylation site which targets it for 
degradation) was floxed, and then crossed it to our Foxd1-Cre line to generate Foxd1-
Cre ;Ctnnb1ex3lox/ ex3lox , a specific gain-of-function (GOF) mutation within the 
prethalamus and hypothalamus.  We hypothesized that we would see a posteriorization 
of the hypothalamus, with an expansion of posterior markers and a corresponding 
reduction in anterior markers.  The result, however, was much more complex, and less 
straightforward, than we anticipated (these results are summarized in Figure 15).    
We observed an overall hyperproliferation phenotype (via EdU staining, 
Figure 7C) resulting in a gross morphological defect consisting of a bend in the ventral 
surface of the hypothalamus, forming two bulges on either side.  This defect can be 
seen most clearly via MRI (Figure 8).  The MRI demonstrated that the 3rd ventricle 
was distended and misshapen in the GOF mutants.  This had the effect of disrupting 
the normal organization of the radial glia which form the ventricular zone.  In addition, 
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the neuroepithelium of the hypothalamus was significantly thicker, resulting from the 
hyperproliferation defect.  However, despite these morphological changes, there was 
no alteration in the position of the diencephalic-telencephalic junction (DTJ), 
delineated by Foxg1 expression in the telencephalon (Figure 10 E, F).  
The canonical Wnt-signaling effector gene, Lef1, is normally expressed in the 
premammillary (green arrowhead, Figure 9I), ID (open arrowhead, Figure 9I), anterior 
hypothalamus (yellow arrowhead, Figure 9I), and prethalamus bordering the ZLI (red 
arrowhead and black arrowhead, respectively, Figure 9I).  In Foxd1-Cre;Ctnnb1ex3/ ex3  
mice,  Lef1 staining was expanded, filling the entirety of the hypothalamus and 
prethalamus (Figure 9J).  However, there was a clear mosaicism to the signal, 
suggesting that the Cre was not fully efficient. 
There were two posterior markers which were expanded, as we expected: Pitx2 
in the supramammillary and mammillary (open arrowheads, Figure 9 K, L; open 
arrowheads, Figure 12 S-X) and Lhx5 in the mammillary (open arrowheads, Figure 9 
O, P), which both showed expansion into the anterior domain.  However, all other 
markers of the posterior hypothalamus were either unaffected, or reduced.  The 
nuclear domain of Foxb1 expression in the mammillary was significantly reduced (black 
arrowheads, Figure 9 G, H), but the migratory Foxb1-positive neuronal population that 
originates in the mammillary was expanded throughout the hypothalamus in the 
mutants (open arrowheads, Figure 9 G, H).  Sim1 staining in the mammillary was 
completely absent (red arrowhead, Figure 10 Q, R), while Emx2 expression was 
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relatively unaffected (Figure 9 E, F).  Wnt8b itself was reduced in the mammillary, 
suggesting a negative feed-back loop (black arrowheads, Figure 9 S, T), while Lhx1 
was reduced but still present in the mammillary (black arrowheads, Figure 9 M, N). 
Another marker which was expanded was Lhx9, a marker of orexinergic cells 
(Shimogori et al., 2010).  Lhx9 is normally expressed in a thin stripe domain in the 
dorsal hypothalamus, just ventral to the Lhx6 stripe of the ID and the hypothalamic 
domain of Arx expression (Shimogori et al. 2010).  In Foxd1-Cre;Ctnnb1ex3/ ex3  mice, 
Lhx9-positive cells were expanded posteriorly, and showed significant disruption of 
the normal condensed stripe pattern (black arrowheads, Figure 9 S, T and Figure 12 
G-L). 
More medial and dorsal structures such as the ID (Lhx1: red-outlined 
arrowhead, Figure 9 M, N; and Lhx6: open arrowhead, Figure 9 Q, R; Figure 12A) and 
the TT (Lhx6: black arrowhead, Figure 9 Q, R; Figure 12 B, C) were completely 
absent.  The PVN appeared to be relatively unaffected.  Sim1 expression was distorted 
by the bending of the hypothalamus, but the overall level was fairly similar (open 
arrowheads, Figure 10 Q, R).  Rax expression in the PVN was potentially expanded 
(open arrowheads, Figure 10 I, J).  
Lhx1 staining in the ventral anterior hypothalamus (and presumptive 
suprachiasmatic nucleus) was lost (open arrowhead, Figure 9 M, N), however Fgf15 in 
the more dorsal portion of the ventral anterior hypothalamus was preserved, albeit 
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more diffuse (open arrowheads, Figure 10 A, B).  In the arcuate, Pomc expression was 
diffuse, mosaic, and severely disorganized, including displaced Pomc-positive cells in 
the dorsal hypothalamus (Figure 10 C, D and Figure 13 A-F).  
We found two main phenotypes when examining stripe markers.  The most 
ventral stripe markers, Rax and Nkx2.1, were both lost from their anterior expression 
domains, with only limited, extremely mosaic 3  expression in the posterior 
hypothalamus remaining (Figure 10 G, H and Figure 13 G-L; black arrowheads, Figure 
10 I, J, respectively).  The more dorsal stripe markers Arx and Isl1, which are both 
expressed in stripes from the prethalamus down through the basal plate of the 
hypothalamus to the anterior hypothalamus, were both significantly down, although 
there was some variability among embryos in the extent of the defect, probably a 
reflection of variability in Cre activity.  In the case of Arx, most Foxd1-Cre;Ctnnb1ex3/ 
ex3  embryos lost all expression in the hypothalamus (open arrowheads, Figure 11 A-F), 
although one embryo tested had some diffuse Arx staining in its large hypothalamic 
mass (data not shown).  Isl1 expression was completely absent from one Foxd1-Cre 
;Ctnnb1ex3/ ex3  mouse (data not shown).  In another, there was diffuse staining in the 
                                                          
3 The mosaicism observed with many of the markers tested as well as Lef1 itself is likely a function 
of the Cre and its incomplete excision activity.  We suspect that much of the mosaicism may reflect 
cells which have failed to excise the autoinhibitory domain of the β-catenin gene.  The only way to 
test this would be to perform two-color in situ hybridization to determine if there is any co-
localization between Lef1 and the mosaic expressed genes (Pomc, Fgf15, Rax, and Nkx2.1); we 




hypothalamic mass, much like the staining seen with Arx (open arrowheads, Figure 11 
M-R).  There was one mutant in which Isl1 expression was reduced, but present in the 
correct location in the hypothalamus, and its expression in the anterior hypothalamus 
was preserved as well (open and red arrowheads, respectively, Figure 10 M, N).  The 
morphogen Shh, which is also expressed in a stripe extending through the ZLI and 
basal plate of the hypothalamus, was completely unaffected in the hypothalamus (open 
arrowheads, Figure 10 K, L). 
Since Foxd1, and thus the Foxd1-Cre, is expressed in the prethalamus and 
adjacent to the ZLI (an organizer regulating development of the thalamus), and since 
Lef1 is also expressed in the prethalamus with a strong zone of expression along the 
ZLI, we expected to observe a patterning defect in these areas.  However, the ZLI was 
completely unaffected, as indicated by expression of Shh (black arrowheads, Figure 10 
K, L), Pitx2 (black arrowheads, Figure 9 K, L; Figure 12 S, V), Lhx1 (green arrowheads, 
Figure 9 M, N; black arrowheads, Figure 11 S-X), Lhx5 (expressed in a zone adjacent 
to the ZLI; black arrowheads, Figure 9 O, P), and Sim1 (black arrowheads, Figure 10 
Q, R).  Development of the prethalamus was disrupted, but it was not a patterning 
defect per se.  The prethalamus was moderately reduced in size, but still expressed the 
markers Fgf15 (black arrowheads, Figure 10 A, B) and Gsh2 (Figure 9 C, D).  Arx 
(black arrowheads, Figure 9 A, B and Figure 11 A-F) and Isl1 (black arrowheads, 
Figure 10 M, N and Figure 11 M-R) were both reduced to a small portion immediately 
adjacent to the ZLI.  Lhx1 was completely absent from the prethalamus (red 
96 
 
arrowhead, Figure 9 M, N).  In contrast, the thalamic eminence, which sits directly 
adjacent and anterior to the prethalamus, was completely preserved in the GOF 
mutants as indicated by Lhx1 (yellow arrowheads, Figure 9 M, N), Lhx5 (yellow 
arrowheads, Figure 9 O, P), Lhx9 (yellow arrowheads, Figure 9 S, T) and Wnt8b (red 
arrowheads, Figure 10 S, T).  
In collaboration with Richard Dorsky, we tested two markers which had been 
pulled out of a RNA-Seq screen his lab performed on Lef1-knockout zebrafish: Bsx 
and Ntng2.  Both of these genes are expressed in a dorsal stripe in the premammillary, 
although Bsx also has an arcuate domain and Ntng2 is expressed in a stripe through 
the ZLI.  Given that they were significantly reduced in the Lef1-/- zebrafish, we 
expected to see an expansion in these markers in our GOF mutants.  Bsx was 
preserved (but not expanded) in the premammillary (black arrowheads, Figure 11 G-
L) but was completely absent from the arcuate domain (open arrowheads, Figure 11 
G-L).  In contrast, Ntng2 in the premammillary was significantly expanded, as we 
expected (open arrowheads, Figure 10 O, P and Figure 12 M-R) although the ZLI 
expression domain was normal (black arrowheads, Figure 10 O, P and Figure 12 M-
R). 
Intriguingly, while the Nkx2.1-Cre;Ctnnb1lox/lox  LOF mutants had a displaced 
pituitary invading the hypothalamus proper, in our Foxd1-Cre ;Ctnnb1ex3/ ex3  GOF 
mutants we observed the exact opposite phenotype, although there was considerable 
variability in the severity of the phenotype.  Instead of migrating from the oral 
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ectoderm to the ventral hypothalamus, the anterior pituitary remained stuck to the 
room of the mouth (red arrowhead, Figure 14 A-B).  In addition, there was a fate 
change within the pituitary.  Normally, only the intermediate lobe expresses Pitx2 and 
Pomc but in the GOF mutants, the entire pituitary expressed Pomc (black arrowheads, 
Figure 14 A, B) and the Pitx2 expression domain was significantly expanded (black 
arrowheads, Figure 14 C, D). 
 
3.1.4 Constitutively Active Shh Signaling Does Not Disrupt Hypothalamic 
Patterning  
 
Our study of canonical Wnt regulation of hypothalamic and prethalamic patterning via 
knockdown and over-activation of its effector protein is a classic approach at teasing 
out the functions of known signaling molecules.  This method, although very fruitful 
in some ways, does not take into account the developmental milieu in which Wnt is 
operating.  In the hypothalamus, Wnt is expressed concurrently and in a partially 
overlapping expression domain with another important morphogen, Shh, although 
Shh’s expression begins earlier and changes dynamically over the course of 
development.  We hypothesized that the complex phenotype observed in Foxd1-
Cre;Ctnnb1ex3/+  mice might be a result of concurrent changes in Shh signaling, which 
would explain why we do not see a simple posteriorization phenotype as expected. 
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        Previous research has looked at the effects of loss-of-function of Shh signaling 
on development of the hypothalamus (Shimogori et al., 2010).  They used Nkx2.1-Cre 
to delete Shh from the hypothalamic neuroepithelium starting at approximately 
E9.5.  In contrast to the anteriorization we observed using the same Cre to knockdown 
canonical Wnt signaling in the hypothalamus, they observed the opposite phenotype: 
a loss of anterior hypothalamic markers and a preservation of posterior markers 
resulting in an overall posteriorization of the hypothalamus.  Combining these two 
data sets starts to paint a picture of how hypothalamic patterning might occur under 
the dueling forces of the posteriorizing Wnt and the anteriorizing Shh, however, a 
study performed in zebrafish complicates this simple narrative and may help explain 
our complex GOF phenotype.  In their study, Wnt was found to inhibit Foxb1 
expression in the mammillary, a posterior structure, while Shh was necessary to drive 
its expression.  This may explain why Foxb1 was lost in the mammillary in both the 
Nkx2.1-Cre;Shhlox/lox LOF and the Foxd1-Cre ;Ctnnb1ex3/+  Wnt GOF mutants.   
To better understand how these two morphogens might work in concert to 
pattern the hypothalamus, we used a similar approach to our Wnt GOF mice to 
generate a Shh GOF mouse using the Foxd1-Cre driver. We utilized a mouse line which 
has a constitutively active point mutation (W539L) of its smoothened (Smo) gene, 
however expression of this gene is prevented by a floxed STOP fragment placed in-
between the promoter and the gene sequence so that the gene is only expressed after 
recombination by Cre.  In the Shh pathway, Smo is a transmembrane protein which is 
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inhibited by the Shh receptor Patched in the absence of ligand; upon Shh binding to 
its receptor the repression is relieved and Smo is able to activate Gli transcription 
factors to affect transcription.  In our case, using Foxd1-Cre, the constitutively active 
Smo would be expressed in every cell of the hypothalamus and prethalamus (Figure 1 
D), generating a Smo GOF mutant embryo. 
We had a two-step approach: first we analyzed the Foxd1-Cre;SmoCA/+ Shh 
GOF embryos at E12.5 to determine what patterning defects, if any, these mutants 
would have, then we created Foxd1-Cre;SmoCA/+;Ctnnb1ex3/+  double GOF mutants, to 
simultaneously activate both Wnt and Shh signaling,  to determine if we could rescue 
the patterning defects observed in the Foxd1-Cre ;Ctnnb1ex3/+  β-catenin GOF 
mutant.  To our great surprise, the Smo GOF single mutants had no discernible 
patterning defect in either the prethalamus or hypothalamus.  The prethalamic 
domains of Arx (black arrowheads, Figure 16 A, B), Isl1 (black arrowheads, Figure 16 
E, F), Lef1 (open arrowheads, Figure 16 G, H), and Lhx1 (open arrowheads, Figure 16 
I, J) were all normal in the Smo GOF mutant, as were the hypothalamic stripe domains 
of Arx (open arrowheads, Figure 16 A, B) and Isl1 (open arrowheads, Figure 16 E, 
F).  The anterior hypothalamus was patterned normally, as indicated by Lef1 and Lhx1 
in the ventral AH (yellow arrowheads, Figure 16 G-J) and Pomc in the arcuate nucleus 
(black arrowheads, Figure 16 K, L).  The posterior hypothalamus was also intact, as 
demonstrated by Lef1 in the premammillary (red arrowheads, Figure 16 G, H), and 
Lhx1 (green arrowheads, Figure 16 I, J) and Foxb1 (black arrowheads, Figure 16 C, D) 
100 
 
in the mammillary.  Normal Lef1 expression also suggested that there was no effect on 
Wnt signaling.  There was similarly no effect on the Foxb1-positive migratory cell 
population (open arrowheads, Figure 16 C, D) in the Smo GOF mutant.  There was 
also no change in the ZLI (Lef1 and Lhx1, black arrowheads, Figure 16 G-J) or 
thalamic eminence (Lhx1, red arrowheads, Figure 16 I, J).     
There was a mild hyperproliferation defect as shown by a thickening of the 
hypothalamic neuroepithelium, although this was not confirmed via EdU cell 
counting.  This can be most clearly seen with Arx, in which the Arx-negative portion 
of the hypothalamus was significantly expanded (red brackets, Figure 16 A, B), and 
with Isl1, in which the Isl1-positive hypothalamic expression domain was considerably 
widened (red brackets, Figure 16 E, F).  However, this hyperproliferation defect was 
too mild to cause the gross morphological defects observed in the β-catenin GOF 
mutant (Figure 8 D-F). 
We then generated Foxd1-Cre;SmoCA/+;Ctnnb1ex3/+  β-catenin/Smo double GOF 
mutants, which appeared to be phenotypically wild-type (Figure 16 M-X).  In contrast 
to the severe patterning defects observed in the Foxd1-Cre;Ctnnb1ex3/+  β-catenin GOF 
single mutant, and the hyperproliferation defects in both the β-catenin and Smo GOF 
single mutants, there was neither a patterning nor a hyperproliferation defect in the 
double GOF mutants, indicating that we had achieved a complete rescue.  The stripe 
markers Arx and Isl1 had normal expression in both the prethalamus (black 
arrowheads, Figure 16 M, N, Q, R) and the hypothalamus (open arrowheads, Figure 
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16 M, N, Q, R).  Foxb1, which had a reduction in the mammillary domain and an 
expansion of the migratory domain in the β-catenin GOF mutant (see Figure 9 G, H) 
was completely normal in the double mutants in both the mammillary (black 
arrowheads, Figure 16 O, P) and migratory cell population (open arrowheads, Figure 
16 O, P).  In contrast, Pitx2, which was expanded in both the supramammillary and 
mammillary in the β-catenin GOF mutants (see Figure 9 K, L), was restricted to its 
normal domain in the double mutants (open arrowheads, Figure 16 U, V).  The 
dramatic expansion of Lef1 in the entire hypothalamus of the Foxd1-Cre;Ctnnb1ex3/+ 
mutants was absent from the double mutants (Figure 16 S, T), and its expression 
domains in the premammillary (red arrowheads), ventral AH (yellow arrowheads), 
prethalamus (open arrowheads) and ZLI (black arrowheads) were once against 
separate and distinct (compare to Figure 9 I, J).  The arcuate expression of Pomc was 
also normal in the double mutant (black arrowheads, Figure 16 W, X), in contrast to 
the mosaic and disrupted Pomc expression domain in the Foxd1-Cre;Ctnnb1ex3/+ β-




Figure 3-1. Wnt and Cre Expression in the Developing Hypothalamus.  
Figure 3-1:  Wnt and Cre Expression in the Developing 
Hypothalamus.  A.  Wnt3/3a and Wnt8a/8b are expressed in a contiguous stripe 
across the developing prethalamus and hypothalamus at E9.5.  B. At E12.5, Wnt3/3a 
are expressed in a stripe across the posterior prethalamus and Wnt8a/8b is restricted 
to the mammillary of the hypothalamus.  At this time, Wnt7a/7b is expressed in 
interneuron progenitors across the hypothalamus.  C-D. Schematics showing where 
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Nkx2.1-Cre (C) and Foxd1-Cre (D) are expressed at E12.5.  Nkx2.1-Cre is restricted to 
a ventral stripe across the anterior-posterior axis and is excluded from the 





Figure 3-2. Loss of β-catenin results in an anteriorization of the hypothalamus: Part 1.  
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Figure 3-2:  Loss of β-catenin results in an anteriorization of the hypothalamus: 
Part 1.  A-T: In situ hybridization of hypothalamic markers on E12.5 control (Cre-
negative, either Ctnnb1lox/lox or Ctnnb1lox/+) and Nkx2.1-Cre;Ctnnb1lox/lox sagittal 
sections.  A-J: Black arrowheads indicate the supramammillary (A-D), mammillary (E-
H) and premammillary (I-J), all of which were reduced in the mutant.  The PVN was 
unaffected (open arrowheads, G and H).  The ID lost Lef1 expression (open 
arrowheads, I and J) but not Lhx6 expression (black arrowheads, K and L).  The TT 
was reduced (open arrowheads, K and L).  M-P: Black arrowheads indicate the 
prethalamus, which was intact in mutants.  Open arrowheads indicate the 
hypothalamic stripe domain, which was ventralized in the mutants.  Red bar in O 
represents the Arx-negative hypothalamic domain which was missing in the 
mutant.  Q-T: Anterior structures were expanded into the posterior domain.  Q-R: 
black arrowheads indicate the arcuate. S-T: black arrowheads indicate the VMH.  U: 








Figure 3-3:  Loss of β-catenin results in an anteriorization of the hypothalamus: 
Part 2.  A-B’: In situ hybridization of hypothalamic markers on E12.5 control (Cre-
negative, either Ctnnb1lox/lox or Ctnnb1lox/+) and Nkx2.1-Cre;Ctnnb1lox/lox coronal sections. 
A-H: The TT (open arrowheads) was lost and ID (black arrowheads) ventralized in 
the mutant. I-B’: Anterior structures were expanded posteriorly in the mutants.  I-R: 
black arrowheads indicate the arcuate. S-B’: black arrowheads indicate the VMH and 




Figure 3-4. Loss of β-catenin results in an anteriorization of the hypothalamus: Part 3.  
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Figure 3-4:  Loss of β-catenin results in an anteriorization of the hypothalamus: 
Part 3.  A-U: In situ hybridization of hypothalamic markers on E12.5 control (Cre-
negative, either Ctnnb1lox/lox or Ctnnb1lox/+) and Nkx2.1-Cre;Ctnnb1lox/lox coronal sections. 
A-J: The mammillary was reduced (black arrowheads) but the PVN was unaffected 
(open arrowheads).  K-U: The hypothalamic neuroepithelium was thinned in the 




Figure 3-5. Knock-down of β-catenin results in a thinning and anteriorization of the hypothalamus but has 
no effect on the prethalamus: Part 1.  
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Figure 3-5:  Knock-down of β-catenin results in a thinning and anteriorization 
of the hypothalamus but has no effect on the prethalamus: Part 1.  A-T: In situ 
hybridization on E12.5 control (Cre-negative, either Ctnnb1lox/lox or Ctnnb1lox/+) and 
Foxd1-Cre;Ctnnb1lox/lox sagittal sections.  A-D: Black arrowheads indicate the 
prethalamus, which was unaffected in the mutants.  White arrowheads indicate the 
thinned hypothalamic domain.  The Lef1 domain of the ID was absent in the mutants 
(red arrowhead, E and F) but the Lhx6 domain was unaffected (open arrowhead, G 
and H).  The TT was gone (black arrowheads, G and H).  E, F: The premammillary 
domain of Lef1 was reduced (open arrowheads), as was the prethalamic domain (black 
arrowheads), and the anterior domain was absent in the mutants (yellow arrowhead). 
I, J: The thalamic eminence was unaffected (open arrowheads), as were the orexigenic 
neurons labelled by Lhx9, although this domain was ventralized (black arrowheads). 
K-N, S, T: Markers encompassing the supramammillary and mammillary were reduced 
in the mutants (open arrowheads).  The PVN was unaffected in the mutant (black 
arrowheads, K, L, Q, and R). The Otp domain of the anterior hypothalamus was 
unaffected (red arrowheads, K and L) but Pomc in the arcuate was expanded into the 
posterior domain (black arrowheads, O and P).  The ZLI was unaffected (black 
arrowheads, M, N, S and T; open arrowheads, Q, R).  The pituitary was displaced into 
the hypothalamic neuroepithelium (red arrowheads, S and T). U: A schematic showing 




Figure 3-6. Knock-down of β-catenin results in a thinning and anteriorization of the hypothalamus but has 
no effect on the prethalamus: Part 2.  
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Figure 3-6:  Knock-down of β-catenin results in a thinning and anteriorization 
of the hypothalamus but has no effect on the prethalamus: Part 2.  In situ 
hybridization on E12.5 control (Cre-negative, either Ctnnb1lox/lox or Ctnnb1lox/+) and 
Foxd1-Cre;Ctnnb1lox/lox coronal sections.  A-L: The hypothalamic domains were reduced 
(open arrowheads), but the prethalamic domains were unaffected (black 
arrowheads).  M-R: Precursors of orexinergic hypocretin neurons (marked here by 
Lhx9 expression) were normal, but ventralized due to the thinned hypothalamus (black 
arrowheads).  S-X: The arcuate (black arrowheads) was displaced due to the invasion 




Figure 3-7. Knock-down of β-catenin had no effect on proliferation, but constitutively active β -catenin 
increased proliferation.  
Figure 3-7:  Knock-down of β-catenin had no effect on proliferation, but 
constitutively active β-catenin increased proliferation.  A-C: EdU and DAPI 
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staining after a 2hr EdU pulse in coronal E12.5 sections from Foxd1-Cre-
negative;Ctnnb1lox/lox, Foxd1-Cre;Ctnnb1lox/lox and Foxd1-Cre;Ctnnb1ex3/+embryos. Red 
scroll bars indicate the boundary of the prethalamus and hypothalamus.  D: 





Figure 3-8. Disrupted ventricular organization in a constitutively active β -catenin embryo.  
Figure 3-8:  Disrupted ventricular organization in a constitutively active β-
catenin embryo.  A-F: MRI on Foxd1-Cre-negative;Ctnnb1ex3/+ (A-C) and Foxd1-
Cre;Ctnnb1ex3/+ GOF (D-F) E12.5 embryos.  A, D: dashed line indicates the level at 
which the horizontal sections in B, C, E and F were taken.  C and F: Colored lines 
indicate the orientation of the fiber tracts, which can either represent axons or radial 
glia, but in this case most likely represents radial glia.  The hypothalamic 




Figure 3-9. Constitutively active β-catenin results in disrupted patterning and development of the 
hypothalamus and prethalamus: Part 1. 
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Figure 3-9:  Constitutively active β-catenin results in disrupted patterning and 
development of the hypothalamus and prethalamus: Part 1. A-T: In situ 
hybridization on E12.5 control (Foxd1-Cre-negative;Ctnnb1ex3/+) and Foxd1-
Cre;Ctnnb1ex3/+ sagittal sections.  A-D: Black arrowheads indicate the prethalamus, 
which was absent except for a tiny sliver in B, and reduced but still present in D.  E-
H: The mammillary is reduced in the GOF mutants.  Black arrowheads indicate the 
mammillary, open arrowheads indicate the migratory Foxb1-expressing cells which 
were expanded into the anterior domain in the GOF mutants.  I-J: Lef1 was expanded 
throughout the hypothalamus, indicating a successful upregulation in canonical Wnt 
signaling. Red arrowheads=prethalamus, black arrowheads=ZLI adjacent, green 
arrowhead=premammillary, open arrowhead=ID, yellow arrowhead=ventral AH.  K-
L: The supramammillary and mammillary (open arrowheads) were expanded in the 
GOF mutant and the ZLI expression was maintained (black arrowheads). M-T: Lim 
homeodomain transcription factors were differentially disrupted by constitutively 
active β-catenin. M-P, S, T: Yellow arrowheads designate the thalamic eminence, 
which was unaffected in the GOF mutants.  M-N: The prethalamus was absent (red 
arrowhead), while the mammillary was reduced (black arrowheads).  The ZLI was 
unaffected (green arrowheads).  The anterior and ID domains were absent (open 
arrowhead and red-outlined arrowhead, respectively).  O-P: Lhx5 was expanded in the 
mammillary (open arrowheads) and unaffected in the ZLI-adjacent (black 
arrowheads). Q-R: Lhx6 was completely absent from the ID (open arrowhead) and 
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TT (black arrowhead).  S-T: Orexigenic neurons were expanded in the GOF mutant 





Figure 3-10. Constitutively active β-catenin results in disrupted patterning and development of the 
hypothalamus and prethalamus: Part 2. 
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Figure 3-10:  Constitutively active β-catenin results in disrupted patterning and 
development of the hypothalamus and prethalamus: Part 2. A-T: In situ 
hybridization on E12.5 control (Foxd1-Cre-negative;Ctnnb1ex3/+) and Foxd1-
Cre;Ctnnb1ex3/+sagittal sections.  A-B: Fgf15 expression was preserved in the 
prethalamus (black arrowheads) and dorsal anterior hypothalamus (open 
arrowheads).  C-D: The arcuate (open arrowheads) was severely disrupted in the GOF 
mutant.  E-F: There was no shift in the location of the DTJ (black arrowheads).  G-J: 
In the mutant, ventral stripe markers were reduced to their posterior domain and were 
extremely mosaic (black arrowheads).  The PVN was unaffected (open arrowheads, I, 
J, Q, R). K-L: Expression of the morphogen Shh was unaffected in the 
supramammillary/mammillary (open arrowheads).  The ZLI was unaffected (black 
arrowheads, K, L, O-R).  M-N: Expression of the stripe marker Isl1 was reduced in 
the prethalamus (black arrowheads), hypothalamus (open arrowheads), but not the 
ventral AH (red arrowheads).  O-P: The dorsal premammillary was expanded (open 
arrowheads).  Staining in the mammillary of the GOF mutants was either completely 
absent (red arrowhead, Q, R) or reduced (black arrowheads, S, T).  The anterior 
domain of Wnt8b expression was unaffected (open arrowheads, S, T).  U: A schematic 




Figure 3-11. Constitutively active β-catenin results in disrupted patterning and development of the 
hypothalamus and prethalamus: Part 3. 
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Figure 3-11:  Constitutively active β-catenin results in disrupted patterning and 
development of the hypothalamus and prethalamus: Part 3.  A-X: In situ 
hybridization on E12.5 control (Foxd1-Cre-negative;Ctnnb1ex3/+) and Foxd1-
Cre;Ctnnb1ex3/+ coronal sections. A-F, M-R:  The prethalamic (black arrowheads) and 
hypothalamic (open arrowheads) expression domains were reduced.  G-L:  The 
premammillary domain of Bsx was present (black arrowheads) but the arcuate 
expression was lost (open arrowheads) in the GOF mutant.  There was ectopic 
expression in the developing habenula (red arrowhead).  S-X:  Lhx1 expression in the 
ZLI (black arrowheads), prethalamus (open arrowheads), ID (red arrowheads), 
anterior hypothalamus (yellow arrowhead) and mammillary (green arrowheads) was 




Figure 3-12. Constitutively active β-catenin results in disrupted patterning and developm ent of the 
hypothalamus: Part 1. 
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Figure 3-12:  Constitutively active β-catenin results in disrupted patterning and 
development of the hypothalamus: Part 1.  A-X: In situ hybridization on E12.5 
control (Foxd1-Cre-negative;Ctnnb1ex3/+) and Foxd1-Cre;Ctnnb1ex3/+ coronal 
sections.  Lhx6 was lost in the ID (open arrowhead, A-F) and TT (black arrowheads, 
A-F), but Lhx9 in the orexigenic neurons (black arrowheads, G-L), Ntng2 in the 
premammillary (open arrowheads, M-R) and Pitx2 in the 
supramammillary/mammillary region (open arrowheads, S-X) were all expanded.  The 




Figure 3-13. Constitutively active β-catenin results in disrupted patterning and development of the 
hypothalamus: Part 2. 
Figure 3-13:  Constitutively active β-catenin results in disrupted patterning and 
development of the hypothalamus: Part 2.  Constitutively active β-catenin results 
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in a disrupted and expanded arcuate (A-F) and ventral hypothalamus (G-L) and mosaic 
expression of Pomc (black arrowheads, A-F) and Rax (black arrowheads, G-L). I: Open 




Figure 3-14. The specification and migration of the pituitary is disrupted by constitutively active β -
catenin. 
Figure 3-14:  The specification and migration of the pituitary is disrupted by 
constitutively active β-catenin. A-D: In situ hybridization on E12.5 control (Foxd1-
Cre-negative;Ctnnb1ex3/+) and Foxd1-Cre;Ctnnb1ex3/+sagittal sections.  In constitutively 
active β-catenin mutant embryos, the pituitary was enlarged and had expanded 
expression of pituitary markers Pomc (black arrowheads, A, B) and Pitx2 (black 
arrowheads, C, D).  In at least one mutant, the pituitary remained stuck to the oral 
ectoderm (junction is indicated by red arrowhead in B).  Open arrowheads in A, B 




Figure 3-15. Schematic demonstrating the developmental changes observed in β -catenin LOF and GOF 
mutant embryos.  
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Figure 3-15:  Schematic demonstrating the developmental changes observed in 
β-catenin LOF and GOF mutant embryos.  In LOF mutants, the hypothalamus 
was anteriorized, and thinned resulting in more dorsal structures shifting 
ventrally.  The prethalamus was unaffected.  In GOF mutants, the phenotype was 
much more complex, with some posterior markers expanded but others lost.  For the 
most part, anterior markers were preserved but reduced and often mosaic.  The 
prethalamus was smaller in size and missing expression of some, but not all 




Figure 3-16. Constitutively active Smo had no effect on patterning.  
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Figure 3-16:  Constitutively active Smo had no effect on patterning.  
Constitutively active Smo had no effect on patterning of the hypothalamus or 
prethalamus, but does cause increased proliferation; constitutively active Smo/β-
catenin double mutants rescue the defects seen in constitutively active β-catenin single 
mutants.  In situ hybridization performed on E12.5 control (Foxd1-Cre-
negative;SmoCA/+) and Foxd1-Cre;SmoCA/+ (A-L) and control (Foxd1-Cre-
negative;Ctnnb1ex3/+;SmoCA/+) and Foxd1-Cre ;SmoCA/+;Ctnnb1ex3/+ (M-X) sagittal 
sections.  Other than a deformed, hyperproliferative hypothalamus, there were no 
patterning defects observed with any markers tested.  Arx and Isl1 expression in the 
prethalamus (black arrowheads, A, B, E, F) and hypothalamus (open arrowheads, A, 
B, E, F) were normal, but the hypothalamic domain was expanded (red 
brackets).  Both the Foxb1 nuclear mammillary domain (black arrowheads, C, D) and 
the migratory population of Foxb1 expressing cells (open arrowheads, C, D) were 
unaffected.  G-J: Lef1 and Lhx1 in the prethalamus (open arrowheads), ZLI (black 
arrowheads) and anterior hypothalamus (yellow arrowheads) were normal, as was Lef1 
in the premammillary (red arrowheads, G, H), and Lhx1 in the thalamic eminence (red 
arrowheads, I, J) and mammillary (green arrowheads, I, J).  The arcuate nucleus was 
also normal in the Smo GOF mutants (black arrowheads, K, L).  The GOF double 
mutants were identical to wild-type, in contrast to the severe patterning defects 
observed in the β-catenin GOF single mutants and the hyperproliferative defect seen 
in the Smo GOF single mutants (compare to Figures 9 and 10).  Arx and Isl1 
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expression in the prethalamus (black arrowheads, M, N, Q, R) and hypothalamus 
(open arrowheads, M, N, Q, R) were unaffected.  Both the Foxb1 nuclear mammillary 
domain (black arrowheads, O, P) and the migratory population of Foxb1 expressing 
cells (open arrowheads, O, P) were unaffected.  The ZLI (black arrowheads, S-V) was 
intact.  S, T: In contrast to the dramatic upregulation of Lef1 expression in the β-
catenin GOF mutants, in the double mutants, Lef1 expression had returned to normal 
in the premammillary (red arrowheads), anterior hypothalamus (yellow arrowheads) 
and prethalamus (open arrowheads).  U, V: Pitx2 expression was no longer expanded 
in the supramammillary/mammmillary of the double mutants (open arrowheads).  W, 
X: The arcuate was normal (black arrowheads.  U-X: The pituitary was in the correct 
position and was not misexpressing any pituitary markers (red arrowheads, contrast 








We have demonstrated that canonical Wnt signaling plays an important role in the 
early patterning and specification of the hypothalamus and prethalamus.  We have 
manipulated activity of the canonical Wnt signaling effector protein, β-catenin, using 
two different Cre lines, and used a wide panel of in situ hybridization probes to reveal 
altered expression of specific nuclei markers in each of the experimental 
conditions.  We had two main goals in examining canonical Wnt signaling in the 
hypothalamus and prethalamus:  first to demonstrate that it plays an important 
function in patterning these structures analogously to its role in other brain regions, 
and second, to reveal a common patterning mechanism governing the hypothalamus 
and prethalamus together as a single developmental unit, in opposition to the 
prosomere model of forebrain development.  The results, however, were much less 
straightforward than anticipated.  
 
3.2.2 The Role of Canonical Wnt Signaling in the Patterning and Specification 




Both the Nkx2.1-Cre;Ctnnb1lox/lox and the Foxd1-Cre;Ctnnb1lox/lox LOF mutant lines 
showed an anteriorization of the hypothalamus, although to varying degrees of 
disruption due to the differing efficiencies of the Cre-lines used.  This is consistent 
with the known function of canonical Wnt signaling as a posteriorizing factor during 
neural development, although what is considered posterior is relative and changes over 
the course of development.  Earlier in development, for example, the forebrain is 
considered an anterior structure and is protected from Wnt signaling by the secretion 
of Wnt antagonists from the prechordal plate (Shinya et al., 2000; Dorsky et al., 2003).  
Within the diencephalon (of which the hypothalamus is the most rostral component), 
the anterior-posterior dichotomy shifts over the rostrocaudal axis.  Wnt signaling is 
thought to pattern the thalamus as well, as it is necessary to prevent the thalamus from 
adopting a prethalamic fate; in this case the prethalamus is considered the anterior 
structure, although the prethalamus is posterior to the anterior hypothalamus 
(Hagemann and Scholpp, 2012).   
We believe that mammillary–derived Wnt8b is likely mediating the patterning 
of the hypothalamus, which would be consistent with research in zebrafish (Kim et al., 
2002; Lee et al., 2006).  Surprisingly, Wnt8b-/- mice have no discernible defects in 
patterning in the diencephalon (Fotaki et al., 2010).  It is likely that other Wnts are 
compensating for the loss of Wnt8b in these mutants, with the best candidate being 
Wnt8a, which is expressed in a very similar pattern to Wnt8b.  However the authors 
of the paper only looked at three markers of the diencephalon, one of which was Isl1, 
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a gene which was ventralized in our β-catenin LOF mutants, but whose expression 
levels did not necessarily change.   
Regardless of which Wnt is mediating the effects, the overall phenotypes in 
both β-catenin LOF mutants were consistent.  All posterior markers tested were 
reduced, and all anterior markers tested were expanded into the posterior domain.  We 
expected to see the complete opposite phenotype in the Foxd1-Cre;Ctnnb1ex3/+ GOF 
mutant, i.e. a reduction in all anterior markers and an expansion of all posterior 
markers into the anterior domain, but this was not the case for the majority of markers 
tested.  It appeared that in the case of the GOF mutant, the specification of individual 
genes within each nucleus had become uncoupled from one another and their broader 
nuclear fate.   For example, while Pitx2 and Lhx5 were expanded in the mammillary, 
Foxb1, Emx2, and Lhx1 were all reduced.  Thus, each gene has differential 
requirements for, and interactions with, β-catenin and canonical Wnt signaling.   
A good example of this is the Lim homeodomain family of transcription 
factors.  Lhx1 and Lhx5 are known in zebrafish to inhibit Wnt signaling by inducing 
expression of the Wnt inhibitors sFRPs (Hagemann and Scholpp, 2012; Peng and 
Westerfield, 2006; Peukert et al., 2011).  In Lhx5 zebrafish morpholinos, the forebrain 
is significantly disrupted and Wnt8b is expanded into what remains of the forebrain 
(Peng and Westerfield, 2006).  This is consistent with the loss or reduction of Lhx1 in 
its various expression domains.  However in Lhx5-/- mice, there are no gastrulation 
defects as observed in zebrafish, and in the case of our GOF mutants, Lhx5 was 
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expanded in the mammillary, suggesting that the interactions between β-catenin and 
Lhx5 may differ across species.  It may also be a reflection of the different 
developmental time points, as gastrulation occurs well before the patterning 
mechanisms described here.  In the case of Lhx9, Lef1 has been shown to be co-
expressed with Lhx9 in the mouse thalamus, and Lhx9/Lhx2 double KO mice have a 
reduction in Lef1 expression in the thalamus (Peukert et al., 2011).  This is consistent 
with the expansion of Lhx9 observed in our GOF mutants.  There appeared to be 
little effect on Lhx9 in the Foxd1-Cre;Ctnnb1lox/lox LOF mutant, but this was not a 
complete knock-out of β-catenin, and it may not have been a significant enough 
reduction to affect Lhx9 expression.     
In the anterior hypothalamus, Lhx1 was the only marker that was lost 
completely.  Other markers were preserved, such as Pomc in the arcuate, Fgf15 in the 
dorsal anterior hypothalamus, Otp in the ventral anterior hypothalamus, Rax in the 
PVN, Wnt8b in the anterior hypothalamus, and Sim1 in the PVN.  Markers of the PVN 
were not affected in either the LOF or GOF mutants, suggesting that this nucleus 
does not require canonical Wnt signaling for its development, and may not even be 
competent to respond to Wnt signaling, although this could be tested by using a 
reporter of Wnt-responsive cells.  There is a small, local source of Wnt8b, and 
corresponding Lef1 expression, in the anterior hypothalamus.  This local source may 
have served to ‘protect’ the anterior markers in the GOF mutant, since they are capable 
of expression even under elevated basal levels of Wnt signaling.  This would explain 
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why the only portion of Isl1 expression remaining in the Foxd1-Cre;Ctnnb1ex3/+ 
hypothalamus was in the anterior hypothalamus.  However both Pomc and Fgf15 
showed disrupted, mosaic expression.  This may simply be the result of mosaicism in 
Foxd1-Cre activity, as demonstrated by the patchy Lef1 staining in the hypothalamus.  
If this were the case, then double staining between Lef1 and Pomc or Fgf15 should 
reveal no co-labeling.  However, an alternative possibility is that the constitutively 
active β-catenin disrupted normal expression of adhesion molecules, preventing 
proper nuclear aggregation.  Research in the thalamus has linked canonical Wnt 
signaling to control of Pcdh10b expression, and cells in the caudal and rostral thalamus 
intermingle when these areas express similar levels of Pcdh10b (Peukert et al., 2011).    
A puzzling result in the Foxd1-Cre;Ctnnb1lox/lox LOF mutant was the clear 
thinning of the hypothalamic neuroepithelium, but without a concomitant decrease in 
proliferation or increase in apoptosis, as determined via EdU staining and TUNEL 
staining, respectively.  It is possible that we simply did not look early enough; 
neurogenesis in the hypothalamus begins at approximately E10.5, and we may have 
observed an effect had we done an EdU pulse or TUNEL staining at that 
age.  Another possible reason that we did not see a change in proliferation was that we 
counted cells within both the hypothalamus and prethalamus.  The prethalamus was 
not affected in the LOF mutants, and by including it in the cell counts, we may have 
inadvertently masked a small but significant change in proliferation in the 
hypothalamus.  Interestingly, early conditional Rax knock-out embryos also have a 
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significant thinning of the hypothalamus, but no concomitant decrease in proliferation 
or increase in TUNEL at E11.5, which the researchers were unable to explain 
(Orquera et al., 2016).   
One of the main unanswered questions arising from our results is what 
becomes of the cells in the large Lef1-positive hypothalamic mass in the Foxd1-
Cre;Ctnnb1ex3/+ GOF mutant.  Although there were several markers that were expanded 
(Pitx2, Lhx5, Lhx9, Ntng2), there were many parts of the hypothalamus that only 
expressed Lef1 (which is a readout of constitutively active β-catenin, and not 
necessarily indicative of a premammillary fate change).  Follow-up studies need to be 
performed to determine the fate of these cells, such as staining for Sox2, which is a 
marker of undifferentiated hypothalamic neurons, which would suggest that these cells 
are locked in an undifferentiated state.  This would be consistent with other research 
which has shown that in some cases, cells which normally require canonical Wnt 
signaling for their specification must downregulate β-catenin before completing 
differentiation (Wrobel et al., 2007).  For example in the midbrain, in the presence of 
constitutively active β-catenin, cells which have already been specified towards a 
dopaminergic fate are precluded from fully differentiating (Joksimovic et al., 
2009).   An alternative way to test this would be to look at expression of Wnt inhibitors 




3.2.3 The Prethalamus and the Prosomere Model 
 
We would have expected, were the prethalamus and hypothalamus patterned together 
as we hypothesized, that there would be a patterning defect within the prethalamus 
and potentially a fate switch between these two structures or within the prethalamus 
itself.  This is not what we observed.  The prethalamus was completely unaffected in 
both β-catenin LOF mutants, and was significantly disrupted in the β-catenin GOF 
mutant, but it was not a patterning defect per se.  Rather, the prethalamus was reduced 
in size and maintained expression of some, but not all, region-specific markers.   
 The prethalamic markers which were lost -- Isl1, Arx, and Lhx1 --, are all 
markers of GABAergic neurons, while the retained markers, Fgf15 and Gsh2, are both 
neural progenitor markers.  This suggests that in the presence of constitutively active 
β-catenin, the prethalamus was frozen in a partially undifferentiated state.  This is in 
keeping with other research on prethalamic development, which has shown that the 
prethalamus must actively inhibit Wnt in order to be fully specified, in contrast to the 
thalamus, which requires Wnt signaling to prevent it from adopting a prethalamic fate 
(Bluske et al., 2012; Peng and Westerfield, 2006; Hagemann and Scholpp, 2012).  This 
would also explain why the prethalamus fails to fully differentiate in the presence of 
constitutively active canonical Wnt signaling, and is not affected by the loss of β-
catenin, even though it is in close apposition to a source of Wnt in the posterior 
hypothalamus.   
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 The lack of a clear patterning phenotype in the prethalamus in any of the 
mutants we examined is inconsistent with our model of a single developmental unit 
comprising the hypothalamus and prethalamus.  Such patterning changes in the 
prethalamus have been observed in other research, but only when signaling to the 
prethalamus was manipulated in the context of studies of thalamic development 
(Bluske et al., 2012).  This would suggest that the prethalamus is being patterned in 
conjunction with the thalamus (in putative prosomere p2), which would also violate 
the prosomere model.  However, in a study of brain diversity in cichlid fish, they 
observed coordinated changes in the relative sizes of the telencephalon and thalamus 
among three species according to their differing ecological needs, but the prethalamus 
and hypothalamus were identical in size across all species.  The fish with a relatively 
larger thalamus showed elevated levels of posteriorizing Wnt1 signaling, while the fish 
with the larger telencephalon were more under the control of Six3 expressed in the 
anterior neuroectoderm (Sylvester et al., 2010).  In this instance, the development of 
the thalamus and prethalamus have become uncoupled from one another, which 
would argue against a common developmental patterning mechanism for these two 
structures.   
 Although our results do not support our original theory of a common 
developmental unit comprising the prethalamus and hypothalamus, nor do they 
support the prosomere model.  One of the stipulations of the prosomere model is that 
the telencephalon is located anterior to the hypothalamus in the so-called secondary 
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prosencephalon, so that the dorso-ventral axis of the prosomere model corresponds 
to the anterior-posterior axis in our model.  The patterning changes that we observed 
in both of our β-catenin LOF mutants argues in favor of our rendering of the anterior-
posterior axis.  Wnt is expected to act as a posteriorizing factor, and the patterning 
shift we observed was entirely along the anterior-posterior axis, and there were no 
patterning shifts along the dorso-ventral axis.  Our results do not fit into any one 
model of forebrain development, but they suggest a system of development that is 
much more complex than the prosomere model would suggest.       
 
3.2.4    A Non-Cell Autonomous Effect on Pituitary Development 
 
One of the more surprising results was the disruption of the pituitary in all three 
mutant lines examined.  Normally, the anterior pituitary forms from the oral ectoderm 
and migrates to meet the posterior pituitary ventral to the hypothalamus.  In both the 
Nkx2.1-Cre;Ctnnb1lox/lox and the Foxd1-Cre;Ctnnb1lox/lox LOF mutants the migrating 
pituitary appeared to have failed to receive any ‘stop’ signal and was invading the 
hypothalamus itself.  In the Foxd1-Cre;Ctnnb1ex3/+ GOF mutant, the opposite 
phenotype occurred.  The pituitary failed to migrate at all, and remained stuck to the 
roof of the mouth.  It also exhibited a fate change, as the Pomc and Pitx2 expression 
domains were significantly expanded.  The effects on pituitary development are non-
cell autonomous as the Foxd1-Cre is not expressed in the pituitary.  Rather, the effect 
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must have been mediated by changes in the hypothalamus, which secretes many 
important signaling molecules important for pituitary development, including Fgfs and 
Bmp7 (Potok et al., 2008).  An apoptotic domain on the ventral side of Rathke’s pouch 
is necessary for successful ‘pinching off’ from the oral ectoderm; this domain is most 
likely lacking in the GOF mutant, perhaps due to increased survival factors from the 
hypothalamus (Davis and Camper, 2007).  Altered levels of noggin and Bmps may be 
mediating the expanded marker domains, as they are known to affect Pomc expression 
in the pituitary (Davis and Camper, 2007).  More research needs to be done to 
determine the cause of the migratory defect in the LOF mutants and the precise cause 
of the fate shift in the GOF mutants.      
 
3.2.5 Wnt and Shh May Cooperatively Pattern the Hypothalamus and 
Prethalamus 
 
One danger in parsing out individual morphogens to look at their separate functions 
is that it risks missing important interactions between signaling pathways.  Individual 
progenitor cells exist within a vast developmental milieu in which they are being 
influenced by cell-autonomous factors, patterning morphogens, as well as the 
developmental fates of their cellular neighbors, and each individual influencer can only 
affect an individual cell’s fate decision in a probabilistic, rather than deterministic 
fashion (Muñoz Descalzo and Arias, 2012).  Wnt may seek to drive an individual cell 
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toward a mammillary fate, for example, but its immediate neighbor may receive the 
same precise level of signal and adopt a premammillary fate instead.  The formation 
of nuclear borders is just as important as the formation of the nuclear body itself, and 
becomes more important as networks begin to be established later in development.  In 
this model, rather than Wnt driving expression of all posterior markers, and Shh 
driving expression of all anterior markers, Shh and Wnt actually work together to both 
specify and then refine development of hypothalamic nuclei.  The hypothalamus is 
unique in the extreme complexity of its anatomy, and so this area may have coopted 
these morphogen systems to ensure not only that these areas are specified correctly, 
but that they are localized within the correct boundaries.  Such a model is suggested 
by their expression patterns themselves, as Shh and Wnt are coexpressed in many of 
the same cells, particularly in the posterior hypothalamus, in contrast to the more 
typical arrangement seen in areas like the spinal cord, where they are expressed in 
opposition to each other on either side of the dorso-ventral axis of the neural tube (Yu 
et al., 2008; Alvarez-Medina et al., 2008).              
            A major complication in parsing out the potential interactions between Wnt 
and Shh signaling in the hypothalamus is that there is no developmental ‘rule’ 
governing such interactions:  they seem to behave differently in different brain areas 
and at different times during development.  For example, Wnt8b in the posterior 
hypothalamus has been shown to be required for the initiation of Shh signaling in the 
formation of the ZLI, by creating a permissive environment for Shh by inhibiting Gli3 
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expression (the main repressor of the Shh pathway) (Martinez-Ferre et al., 2013).  In 
contrast, in the neural tube, dorsal Wnt acting via canonical signaling inhibits Shh 
through activation of Gli3, thereby restricting ventral fates to their proper domain and 
ensuring the correct patterning of the spinal cord (Alvarez-Medina et al., 2008).  And 
in the midbrain, Wnt antagonism of Shh signaling is necessary for floor plate 
neurogenesis (Joksimovic et al., 2009; Joksimovic and Awatramani, 2014).  Thus, 
depending on the timing and context, canonical Wnt signaling can function as a 
repressor or activator of Shh signaling.  This may also reflect the varying competences 
of different neural tissue to respond to Wnt.  β-catenin has no DNA binding domain, 
so its ability to affect transcription and chromatin conformation is entirely dependent 
on the transcriptional state of the cell (Valenta et al., 2012).   
            One clue as to the potential mode of interaction between Shh and Wnt was 
suggested by the surprising loss of Foxb1 expression in the mammillary in the 
constitutively active β-catenin mouse (black arrowheads, Figure 9 G, H).  Previous 
research had shown that in mouse, Shh is necessary for maintenance of Foxb1 
expression in the mammillary, while Wnt signaling, potentially via Wnt8b, can inhibit 
its expression (Szabo et al., 2009).  This runs counter to the model that Wnt is a strictly 
posteriorizing factor, but is consistent with our results, and explains them.  It also 
helps to elucidate a puzzling find from another paper, in which loss of Shh signaling 
in the hypothalamus had a posteriorizing effect with the notable exception of the loss 
of Foxb1 in the mammillary (Shimogori et al., 2010).  Consistent with all of these 
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findings, there was a complete rescue of the Foxb1 phenotype in our double Foxd1-
Cre;Ctnnb1ex3/+;SmoCA/+ GOF mouse (Figure 16 O, P).  However, there was no effect 
on Foxb1 expression in the single Smo GOF mouse (Figure 16 C, D).  This may be 
because in the case of Foxb1 expression, Shh and Wnt are not inhibiting each other 
through direct pathway modulation, but rather Shh and Wnt have opposing effects on 
Foxb1 transcriptional regulation.  In other words, if Shh is not inhibiting the Wnt 
pathway directly, then excess Shh signaling cannot drive Foxb1 expression beyond a 
certain point because of the continued presence of the inhibitory Wnt4.  We suspect 
that any interactions between Shh and Wnt must be indirect, downstream interactions, 
since Shh expression was not affected in the β-catenin GOF mutant, and Lef1 
expression was not affected in the Smo GOF mutant.  
 An important caveat is that in both our single Smo GOF mouse and our 
double β-catenin/Smo GOF mouse, we were not able to directly confirm that the Shh 
pathway was indeed constitutively activated.  This would be shown either through 
upregulation of the Shh co-receptor Ptch, or through its effector genes, Gli1 or Gli3, 
which are analogous to Lef1 in the canonical Wnt signaling pathway.  However, in both 
mutants, there was a loss of retinal pigmented epithelium in the temporal half of the 
eye (where Foxd1 is expressed) indicating that there was successful recombination in 
at least one brain area, although this does not guarantee successful recombination in 
                                                          
4 There was also a loss of Foxb1 expression in both β-catenin LOF mutants tested, but this is likely 
secondary to the overall reduced size of the posterior hypothalamus in these animals.   
147 
 
the hypothalamus.  Further work needs to be done to confirm that we have achieved 
a true double Smo/β-catenin GOF mutant.  However, if it is confirmed, it would 
represent a much more complete rescue than has been achieved previously in the 
diencephalon.  In the thalamus, constitutively active β-catenin has a similarly disrupted 
patterning phenotype as reduced Shh signaling; both result in a fate switch in the 
rostral thalamus towards a more caudal thalamic fate.  However double β-catenin/Shh 
LOF mutants have a similar phenotype as β-catenin single LOF embryos, with the 
exception of a single gene whose expression level and localization was restored to 




Our research is a step towards better understanding of the patterning processes 
underlying the development of the hypothalamus.  We have shown that canonical Wnt 
signaling is most likely acting as a general posteriorizing factor, however it is working 
within the environment of other signaling pathways, and is most likely coordinating its 
activity with theirs.  Specifically, the Shh and canonical Wnt pathways are thought to 
be working downstream of each other in order to both pattern the hypothalamus and 
refine nuclear borders.  Our results do not support a model in which the hypothalamus 
and prethalamus are being patterned together, nor do they support the prosomeric 
model of forebrain development.  More research needs to be done both on the specific 
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mechanisms of Wnt regulation of hypothalamic patterning, and its potential 
interactions with other signaling pathways.   
 
3.3 METHODS AND MATERIALS 
 
3.3.1 Embryo Collection 
 
Matings were set up in the evenings and the presence of a plug the next morning 
indicated embryonic day 0.5 (E0.5).  Embryos were harvested at embryonic day 12.5 
(E12.5).  The lines used were as follows:   
Nkx2.1-Cre (Brault et al., 2001) 
Nkx2.1-cre+/-;Ctnnb1lox/+ 
Foxd1-Cre (Humphreys, et al. 2008) 
Foxd1-Cre+/-;Ctnnb1lox/+ 
 Ctnnb1lox/lox (Brault et al., 2001) 
β-catenin-Ex3f/f (hereafter designated as Ctnnb1ex3/ ex3) (Harada et al, 1999) 
Smo-W539Lf/f (hereafter designated as SmoCA/CA) (Jeong et al., 2004) 
Ctnnb1ex3/ +;SmoCA/+  
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The crosses set up were as follows: 
Foxd1-Cre+/-;Ctnnb1lox/+x Ctnnb1lox/lox  
Foxd1-Cre+/- x Ctnnb1ex3/ ex3   
Foxd1-Cre+/- x SmoCA/CA 
Foxd1-Cre+/- x Ctnnb1ex3/ +;SmoCA/+ 
 
3.3.2 High-Quality Chromogenic In situ Hybridization 
 
Pregnant dams were sacrificed via cervical dislocation and the embryos were harvested 
into ice-cold 1xPBS (phosphate buffered saline) treated with DEPC.  Embryos were 
dissected (tail samples were kept for genotyping) and their whole heads fixed in 4% 
PFA (paraformaldehyde) in 1xPBS-DEPC while rotating at 4⁰C.  Following fixation, 
embryos were washed 2x5 min in 1x-PBS-DEPC then sucrose sunk in 30% sucrose in 
1xPBS-DEPC at 4⁰C for a minimum of one day.  Embryos were then embedded in 
gelatin (10% gelatin with 30% sucrose in 1xPBS-DEPC).  Following hardening of the 
gelatin, the blocks were cut and stored in 4% PFA; 30% sucrose in 1xPBS-DEPC for 
a minimum of one week at 4⁰C to allow the blocks to sufficiently fix before sectioning.   
All steps after this point were done under RNAse-free conditions.  The gelatin blocks 
were sectioned on a freezing microtome at 40µm thickness.  Sections were collected 
150 
 
in 1xPBS-DEPC and stored at 4⁰C until mounting (stored for a maximum of 4 hours).  
Sections were mounted in 0.5x PB-DEPC (phosphate buffer) onto Superfrost Plus 
slides (Fisher Scientific) and allowed to dry vertically for a minimum of overnight to a 
maximum of two days.   Following drying, sections were immediately put through the 
first day of the high-quality in situ hybridization protocol.    All washes were performed 
in 5-slide mailers that had been treated with 0.3M NaOH.  Briefly, slides were fixed in 
4% PFA in 1xPBS-DEPC for 15 minutes followed by 3x5 minute washes in 1xPBS-
DEPC (all done at room temperature).  Slides were then digested in a proteinase K 
solution (1µg/ml in 100mM Tris-HCl pH 8.0 and 50mM EDTA pH 8.0) at 37⁰C for 
30 minutes, followed by another fixation with 4% PFA in 1xPBS-DEPC for 15 
minutes at room temperature.  Slides were then washed in 1xPBS-DEPC (3x5 min).  
At this point, slides were either placed in hybridization buffer and stored at -20⁰C or 
immediately placed in hybridization buffer with probe and hybridized.  For each new 
probe, 70µl probe was added to 1mL of hybridization buffer and heated at 80⁰C in 
order to denature them, then immediately placed on ice before adding to the mailer 
for a total volume of 14mL hybridization buffer (including probe).  Mailers with fewer 
than 5 slides were given RNAse-free blank slides.  Used probe/hybridization solution 
was stored at -20⁰C and used multiple times, refreshing with 15µl probe when needed.  
Slides were hybridized at 70⁰C overnight in a hybridization oven.  After hybridization, 
RNAse-free conditions were no longer necessary.  Slides were incubated in Solution 
X (50% formamide in 2x SSC and 1% SDS) 3x45 min at 70⁰C.  Slides were then 
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washed 3x15 min in 1xTBST (25.0 mM Tris-HCl pH7.5, .136 M NaCl, 2.68 mM KCl, 
1% Tween-20) at room temperature then blocked in 10% lamb serum in 1xTBST at 
room temperature for 1 hr.  Slides were then incubated in preabsorbed primary 
antibody (1:5000 anti-DIG a.p. fab fragments; protocol below) in 1% lamb serum and 
1xTBST, overnight at 4⁰C.  Following antibody incubation, the slides were washed in 
1xTBST 3x15 min, then 1x10 min in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 
9.5, 50 mM MgCl2, 1% Tween-20, 2mM levamisole).  The slides were then developed 
in the color reaction step in NTMT containing the chromogens 5-bromo, 4-chloro, 3-
indolylphosphate (BCIP) and nitroblue tetrazolium (NBT), at either room temperature 
or 4⁰C.  The color reaction was stopped in TE stop buffer (10 mM Tris-HCl pH 7.5, 
50 mM EDTA pH 8.0) for a minimum of 1 hr, followed by DAPI staining for 5 min 
(1:5000 in 1xPBS) then a 1xPBS wash for 5 min.  Slides were coverslipped with gelvatol 
and allowed to dry overnight before imaging.   
 
3.3.3 Preabsorbed Antibody 
 
Age appropriate embryo powder (in this case E12.5 embryo powder made from wild-
type embryo heads) was rehydrated in 1xTBST at 70⁰C for 30 min, rotating.  It was 
cooled on ice for 10 minutes, then the primary antibody was added as well as 1% lamb 
serum.  It was then incubated at 4⁰C for one hour, rotating.  After allowing the solution 
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and embryo powder to settle, the supernatant containing the antibody was taken and 
added to a solution of 1xTBST and 1% lamb serum. 
 
3.3.4 Low-Quality Chromogenic In situ Hybridization 
 
Embryos were harvested fresh frozen and immediately embedded in OCT (Tissue-
tek) and frozen on dry ice.  Blocks were sectioned on the cryostat at 20µm thickness 
and immediately dry mounted onto Superfrost Plus slides.  Slides were allowed to dry 
and then were stored at -80⁰C.  When ready to be used, the slides were allowed to 
thaw at room temperature a minimum of 30 min before beginning the protocol.  The 
first day of the in situ hybridization was done under RNAse-free conditions, and all 
slide boxes and slide holders were soaked in 0.3M NaOH before use.  All incubations 
were done at room temperature unless otherwise noted.  Slides were fixed in 4% PFA 
in 1xPBS-DEPC for 10 min, then washed 3x 5 min in 1xPBS-DEPC.  Slides were then 
incubated in acetic anhydride (.0027% in .1M TEA pH 8.0) for 10 min followed by 
another wash in 1xPBS-DEPC, 3x 5 min.  Slides were then incubated in hybridization 
buffer for 2 hours prior to adding probe in hybridization buffer and coverslipping with 
siliconized coverslips.  Slides were hybridized at 68⁰C overnight.  Probes were 
denatured at 80⁰C for 5 minutes prior to hybridization.  Hybridized slides were washed 
in 5x SSC at 65⁰C for approximately 45 min until the coverslips could be removed 
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easily.  Then the slides were washed in 0.2x SSC, 2x 45 min at 65⁰C, followed by 1x 5 
min at room temperature.  Slides were then washed 1x 5 min in B1 buffer (.2M Tris-
HCl pH 7.5, .3M NaCl) then blocked in 5% heat-inactivated sheep serum in B1 for 1 
hour.  Slides were incubated in primary antibody (1:5000 anti-DIG-AP. in 5% heat-
inactivated in B1) overnight at 4⁰C.  Prior to developing, the slides were washed in B1 
3x 5 min then 1x 5 min in B3 solution (.1 M Tris-HCl pH 9.5, .05 M MgCl2, .1 M 
NaCl).  The color reaction proceeded in B3 with BCIP and NBT with .24mg/mL 
levamisole) under dark conditions at either room temperature or 4⁰C.  The color 
reaction was extinguished in TE stop buffer (10 mM Tris-HCl pH 7.5, 50 mM EDTA 
pH 8.0).  Slides were DAPI stained in 1:5000 DAPI in 1xPBS for 5 min, followed by 
a 1xPBS wash for 5 min before coverslipping with gelvatol.  Slides were allowed to dry 
overnight before imaging.   
  
3.3.5 Whole Mount In Situ Hybridization 
 
All incubations were at room temperature unless otherwise noted, and performed in 
24-well mesh plates.  E9.0 and E10.0 wild-type embryos were harvested in cold 1xPBS-
DEPC.  E10 embryos were cut down the midline of the brain to allow for probe 
access.  Embryos were fixed in 4% PFA in 1xPBS-DEPC for approximately one week.  
After fixation, the embryos were washed 2x15 min in PTw (1% Tween-20 in 1xPBS-
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DEPC) then dehydrated with 25%, 50%, then 75% methanol in PTw for 15 min each 
then 100% methanol in PTw 3x15 min.  Embryos were stored overnight at -20⁰C, 
before they were rehydrated in reverse methanol washes, 75%, 50%, 25% methanol in 
PTw for 15 min each, followed by PTw 2x15 min.  Embryos were then incubated in 
6% hydrogen peroxide in PTw 60 min, followed by PTw wash 2x15 min.  As these 
were young embryos (younger than E13.5) they then had 3x30 min incubations in 
detergent mix (1% Igepal CA-630, 1% SDS, 0.5% Na Deoxycholate, 50mM Tris-HCl 
pH 8.0, 1mM EDTA, 150 mM NaCl) followed by a 10 min PTw wash.  Embryos were 
digested in 10μg/mL Proteinase K in PTw for 20 min, post-fixed in 0.2% 
glutaraldehyde, 4% PFA in PTw for 20 min, then washed in PTw 2x10 min.  A 
prehybridization step followed, with room temperature hybridization buffer added to 
the embryos in sterile glass vials before incubating at 70⁰C for one hour.  Probe was 
added straight to the vials (25μl per 5 mL hybridization buffer) and embryos were 
hybridized overnight at 70⁰C.  Following hybridization, embryos were incubated in 
Solution X 4x45 min.  At this point, the protocol is identical to the high-quality in situ 
hybridization protocol up to and including adding the antibody.  Following antibody 
incubation, the embryos were washed in 1xTBST 3x10 min, 5x60 min, then overnight. 
Embryos were washed in NTMT 3x10 min then incubated in an NBT/BCIP color 
reaction solution at either room temperature or 4⁰C.  Embryos were washed in 
1xTBST to remove the background signal, then the color reaction was stopped in TE 





Probes were generated using the following sequences as templates: 
 































3.3.7 EdU Staining and Cell Counting 
 
Pregnant dams were injected with 50 mg/kg Edu (20 mg/mL in saline) on embryonic 
day E12.5 and then sacrificed via cervical dislocation 2 hours later.  The embryos were 
harvested in ice cold 1xPBS and the whole heads fixed in 4% PFA in 1xPBS at 4⁰C 
overnight, rotating.  The embryos were then washed 2x5 min in 1xPBS at 4⁰C then 
sucrose sunk in 30% sucrose in 1xPBS and stored at 4⁰C for a minimum of one 
day.  Following cryoprotection, the embryos were embedded in OCT blocks on dry 
ice, then sectioned on a cryostat at 25µm thickness.  Sections were immediately dry 
mounted onto Superfrost Plus slides and allowed to dry before storing at -20⁰C.  EdU 
staining was performed using the Click-iT EdU imaging kit from Invitrogen, then the 
slides were coverslipped using Vectashield.  Stained slides were imaged at 40x on a 
Keyence microscope.  Between 5 and 6 sections per animal were counted using 
ImageJ.  All counting was done manually and blinded.  The number of EdU-positive 
cells was taken as a fraction of the total area of the hypothalamus measured in 
µm2.  The values of the sections were averaged for each individual, and then compared 
using a 2-tailed t-test.  Three animals per genotype were used. 
 




E12.5 embryos were harvested and post-fixed in 4% paraformaldehyde for a minimum 
of overnight at 4⁰C.  Slides were sucrose sunk in 30% sucrose in 1xPBS after 3x5 min 
1xPBS washes.  Following sucrose sinking, the embryos were embedded in OCT 
blocks on dry ice, and sectioned on a cryostat at 25μm thickness.  Sections were 
immediately dry mounted onto Superfrost Plus slides and allowed to dry before storing 
at -20⁰C.  Slides were allowed to thaw to room temperature until beginning the 
protocol.  TUNEL staining was performed according to the protocol for 
cryopreserved tissue in the In Situ Cell Death Detection Kit-TMR red (Roche).  A 
positive control was used (3000 U/mL DNAse I).  Slides were DAPI stained then 
coverslipped using Vectashield, then imaged at 20x and 40x in the red channel on a 




MRI was performed on E12.5 wild-type and β-catenin GOF embryos.  MRI data were 
acquired on a Bruker 11.7T spectrometer, using a 10mm volume transceiver coil.  High 
angular resolution diffusion MRI data was acquired at the following parameters: field 
of view = 6x7x7.5mm, 35um isotropic resolution, 4 non-diffusion weighted, 30 
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